ES2354883T3 - COSMETIC PREPARATIONS IN BALL FORM FOR THE TOPICAL APPLICATION. - Google Patents
COSMETIC PREPARATIONS IN BALL FORM FOR THE TOPICAL APPLICATION. Download PDFInfo
- Publication number
- ES2354883T3 ES2354883T3 ES04764494T ES04764494T ES2354883T3 ES 2354883 T3 ES2354883 T3 ES 2354883T3 ES 04764494 T ES04764494 T ES 04764494T ES 04764494 T ES04764494 T ES 04764494T ES 2354883 T3 ES2354883 T3 ES 2354883T3
- Authority
- ES
- Spain
- Prior art keywords
- preparations
- skin
- cosmetic
- preparation
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 110
- 239000002537 cosmetic Substances 0.000 title claims abstract description 64
- 230000000699 topical effect Effects 0.000 title claims description 7
- 150000002632 lipids Chemical class 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000000839 emulsion Substances 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 22
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 15
- 239000000126 substance Substances 0.000 claims description 37
- 239000001993 wax Substances 0.000 claims description 34
- 239000013543 active substance Substances 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 15
- 239000004480 active ingredient Substances 0.000 claims description 14
- 239000003963 antioxidant agent Substances 0.000 claims description 12
- 239000004904 UV filter Substances 0.000 claims description 11
- 239000007787 solid Substances 0.000 claims description 11
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 claims description 10
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 239000000049 pigment Substances 0.000 claims description 8
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 claims description 8
- 239000003086 colorant Substances 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 6
- 239000000123 paper Substances 0.000 claims description 6
- 235000019271 petrolatum Nutrition 0.000 claims description 6
- 229920003023 plastic Polymers 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 150000002191 fatty alcohols Chemical class 0.000 claims description 5
- 239000012188 paraffin wax Substances 0.000 claims description 5
- 239000002304 perfume Substances 0.000 claims description 5
- 230000001953 sensory effect Effects 0.000 claims description 5
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- 229940048851 cetyl ricinoleate Drugs 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 125000005456 glyceride group Chemical group 0.000 claims description 4
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 claims description 4
- 239000004200 microcrystalline wax Substances 0.000 claims description 4
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 4
- 229940078812 myristyl myristate Drugs 0.000 claims description 4
- 238000004806 packaging method and process Methods 0.000 claims description 4
- 235000019809 paraffin wax Nutrition 0.000 claims description 4
- 210000002374 sebum Anatomy 0.000 claims description 4
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 claims description 3
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 3
- 239000004203 carnauba wax Substances 0.000 claims description 3
- 235000013869 carnauba wax Nutrition 0.000 claims description 3
- 229940074979 cetyl palmitate Drugs 0.000 claims description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 3
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 3
- 229920001059 synthetic polymer Polymers 0.000 claims description 3
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 229940092738 beeswax Drugs 0.000 claims description 2
- 239000004204 candelilla wax Substances 0.000 claims description 2
- 235000013868 candelilla wax Nutrition 0.000 claims description 2
- 229940073532 candelilla wax Drugs 0.000 claims description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 claims description 2
- 229920005615 natural polymer Polymers 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 238000003892 spreading Methods 0.000 claims description 2
- 230000007480 spreading Effects 0.000 claims description 2
- 229940098780 tribehenin Drugs 0.000 claims description 2
- 229960001947 tripalmitin Drugs 0.000 claims description 2
- 239000008139 complexing agent Substances 0.000 claims 1
- 239000003398 denaturant Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 229920000642 polymer Polymers 0.000 abstract description 11
- -1 greases Substances 0.000 description 51
- 239000002253 acid Substances 0.000 description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 239000002775 capsule Substances 0.000 description 20
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 17
- 239000002245 particle Substances 0.000 description 14
- 239000012071 phase Substances 0.000 description 14
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 14
- 235000002639 sodium chloride Nutrition 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 13
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000004205 dimethyl polysiloxane Substances 0.000 description 12
- 235000011187 glycerol Nutrition 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 229920006395 saturated elastomer Polymers 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 11
- 229920001577 copolymer Polymers 0.000 description 11
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 11
- 150000003839 salts Chemical class 0.000 description 11
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 238000003860 storage Methods 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 238000000576 coating method Methods 0.000 description 9
- 238000002844 melting Methods 0.000 description 9
- 230000008018 melting Effects 0.000 description 9
- 239000004698 Polyethylene Substances 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 229940008099 dimethicone Drugs 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 229960005323 phenoxyethanol Drugs 0.000 description 7
- 229920000573 polyethylene Polymers 0.000 description 7
- 238000011321 prophylaxis Methods 0.000 description 7
- 229920002545 silicone oil Polymers 0.000 description 7
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 6
- 229920002472 Starch Polymers 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 6
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- 239000000945 filler Substances 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 230000003711 photoprotective effect Effects 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 229940032147 starch Drugs 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 229920001661 Chitosan Polymers 0.000 description 5
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 5
- 244000299461 Theobroma cacao Species 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 235000019219 chocolate Nutrition 0.000 description 5
- 238000005538 encapsulation Methods 0.000 description 5
- 229920000058 polyacrylate Polymers 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 5
- 229910052710 silicon Inorganic materials 0.000 description 5
- 239000010703 silicon Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 5
- 239000011787 zinc oxide Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 241001135917 Vitellaria paradoxa Species 0.000 description 4
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 235000015165 citric acid Nutrition 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 4
- AMTWCFIAVKBGOD-UHFFFAOYSA-N dioxosilane;methoxy-dimethyl-trimethylsilyloxysilane Chemical compound O=[Si]=O.CO[Si](C)(C)O[Si](C)(C)C AMTWCFIAVKBGOD-UHFFFAOYSA-N 0.000 description 4
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical class N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 239000004310 lactic acid Substances 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 229960001679 octinoxate Drugs 0.000 description 4
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 4
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 4
- 229940101267 panthenol Drugs 0.000 description 4
- 239000011619 pantothenol Substances 0.000 description 4
- 235000020957 pantothenol Nutrition 0.000 description 4
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 4
- 229920005862 polyol Polymers 0.000 description 4
- 150000003077 polyols Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 235000019615 sensations Nutrition 0.000 description 4
- 150000004760 silicates Chemical class 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 229940083037 simethicone Drugs 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- 235000019871 vegetable fat Nutrition 0.000 description 4
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical class OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 3
- NIQCNGHVCWTJSM-UHFFFAOYSA-N Dimethyl phthalate Chemical compound COC(=O)C1=CC=CC=C1C(=O)OC NIQCNGHVCWTJSM-UHFFFAOYSA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 3
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 3
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 229940085262 cetyl dimethicone Drugs 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 3
- 235000017471 coenzyme Q10 Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 229960003624 creatine Drugs 0.000 description 3
- 239000006046 creatine Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 235000013310 margarine Nutrition 0.000 description 3
- 239000003264 margarine Substances 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 239000005871 repellent Substances 0.000 description 3
- 230000002940 repellent Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 229940057910 shea butter Drugs 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 229940035936 ubiquinone Drugs 0.000 description 3
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- PFPQMWRASYNLMZ-LGIMBNBCSA-N 2-(3,4-dihydroxyphenyl)-3-[(2s,3r,4r,5s,6r)-3,4-dihydroxy-5-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxy-5,7-dihydroxychromen-4-one Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 PFPQMWRASYNLMZ-LGIMBNBCSA-N 0.000 description 2
- CZVOIAOPRGNENY-UHFFFAOYSA-N 2-butyloctyl 2-hydroxybenzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1O CZVOIAOPRGNENY-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 2
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 2
- KKJKXQYVUVWWJP-UHFFFAOYSA-N 4-[(4,7,7-trimethyl-3-oxo-2-bicyclo[2.2.1]heptanylidene)methyl]benzenesulfonic acid Chemical compound CC1(C)C2CCC1(C)C(=O)C2=CC1=CC=C(S(O)(=O)=O)C=C1 KKJKXQYVUVWWJP-UHFFFAOYSA-N 0.000 description 2
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- MMOXZBCLCQITDF-UHFFFAOYSA-N N,N-diethyl-m-toluamide Chemical compound CCN(CC)C(=O)C1=CC=CC(C)=C1 MMOXZBCLCQITDF-UHFFFAOYSA-N 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 2
- 239000000006 Nitroglycerin Substances 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
- HEAHZSUCFKFERC-LRVMPXQBSA-N [(2e)-2-[[4-[(z)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C/C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-LRVMPXQBSA-N 0.000 description 2
- NBVZMBLJRHUOJR-UHFFFAOYSA-N [amino-[4-[6-[4-[amino(azaniumylidene)methyl]phenoxy]hexoxy]phenyl]methylidene]azanium;2-hydroxyethanesulfonate Chemical compound OCCS(O)(=O)=O.OCCS(O)(=O)=O.C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 NBVZMBLJRHUOJR-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 2
- 229920006318 anionic polymer Polymers 0.000 description 2
- 230000002682 anti-psoriatic effect Effects 0.000 description 2
- 229940030999 antipsoriatics Drugs 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229920002678 cellulose Chemical class 0.000 description 2
- 239000001913 cellulose Chemical class 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 2
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical compound C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 2
- 229960001259 diclofenac Drugs 0.000 description 2
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960000655 ensulizole Drugs 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000007903 gelatin capsule Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229960003711 glyceryl trinitrate Drugs 0.000 description 2
- 229920000591 gum Polymers 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229960001915 hexamidine Drugs 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229960003921 octisalate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 229940100518 polyglyceryl-4 isostearate Drugs 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000005201 scrubbing Methods 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000009974 thixotropic effect Effects 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229940040064 ubiquinol Drugs 0.000 description 2
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- ZCVAOQKBXKSDMS-AQYZNVCMSA-N (+)-trans-allethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OC1C(C)=C(CC=C)C(=O)C1 ZCVAOQKBXKSDMS-AQYZNVCMSA-N 0.000 description 1
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- MAOBFOXLCJIFLV-UHFFFAOYSA-N (2-aminophenyl)-phenylmethanone Chemical compound NC1=CC=CC=C1C(=O)C1=CC=CC=C1 MAOBFOXLCJIFLV-UHFFFAOYSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 1
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 1
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WTXXSZUATXIAJO-OWBHPGMISA-N (Z)-14-methylpentadec-2-enoic acid Chemical compound CC(CCCCCCCCCC\C=C/C(=O)O)C WTXXSZUATXIAJO-OWBHPGMISA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- DWANEFRJKWXRSG-UHFFFAOYSA-N 1,2-tetradecanediol Chemical compound CCCCCCCCCCCCC(O)CO DWANEFRJKWXRSG-UHFFFAOYSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- FMTFEIJHMMQUJI-NJAFHUGGSA-N 102130-98-3 Natural products CC=CCC1=C(C)[C@H](CC1=O)OC(=O)[C@@H]1[C@@H](C=C(C)C)C1(C)C FMTFEIJHMMQUJI-NJAFHUGGSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical group COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- COJBCAMFZDFGFK-VCSGLWQLSA-N 2-O-sulfo-alpha-L-idopyranuronic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1OS(O)(=O)=O COJBCAMFZDFGFK-VCSGLWQLSA-N 0.000 description 1
- FQNKTJPBXAZUGC-UHFFFAOYSA-N 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid Chemical compound OC1=CC(N(CC)CC)=CC=C1C(=O)C1=CC=CC=C1C(O)=O FQNKTJPBXAZUGC-UHFFFAOYSA-N 0.000 description 1
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N 2-amino-4-methylselanyl-butanoic acid Chemical compound C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- KUNNUNBSGQSGDY-UHFFFAOYSA-N 2-butyl-6-methylphenol Chemical compound CCCCC1=CC=CC(C)=C1O KUNNUNBSGQSGDY-UHFFFAOYSA-N 0.000 description 1
- ZGGHMDBVRJATBC-UHFFFAOYSA-N 2-butyloctyl benzoate Chemical compound CCCCCCC(CCCC)COC(=O)C1=CC=CC=C1 ZGGHMDBVRJATBC-UHFFFAOYSA-N 0.000 description 1
- RRSYNAMOFATAOU-UHFFFAOYSA-N 2-cyano-3-(2-octan-3-ylphenyl)-3-phenylprop-2-enoic acid Chemical compound CCCCCC(CC)C1=CC=CC=C1C(=C(C#N)C(O)=O)C1=CC=CC=C1 RRSYNAMOFATAOU-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- NPSJHQMIVNJLNN-UHFFFAOYSA-N 2-ethylhexyl 4-nitrobenzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=C([N+]([O-])=O)C=C1 NPSJHQMIVNJLNN-UHFFFAOYSA-N 0.000 description 1
- LWLRMRFJCCMNML-UHFFFAOYSA-N 2-ethylhexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(CC)CCCC LWLRMRFJCCMNML-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- 239000004808 2-ethylhexylester Substances 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical group CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-N 3,3'-Thiobispropanoic acid Chemical compound OC(=O)CCSCCC(O)=O ODJQKYXPKWQWNK-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- FGGSPCRNKDZEKY-UHFFFAOYSA-N 3-hexoxypentane-1,2,3-triol Chemical compound CCCCCCOC(O)(CC)C(O)CO FGGSPCRNKDZEKY-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- RUEOYQNDBAHZBS-UHFFFAOYSA-N 4-[2-hydroxy-3-(2-hydroxy-3-octadecanoyloxypropoxy)propoxy]-4-oxobutanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCC(O)=O RUEOYQNDBAHZBS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 1
- PJNWEORJORTUQI-UHFFFAOYSA-N 7-methyloctyl nonanoate Chemical compound CCCCCCCCC(=O)OCCCCCCC(C)C PJNWEORJORTUQI-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 229930183010 Amphotericin Natural products 0.000 description 1
- QGGFZZLFKABGNL-UHFFFAOYSA-N Amphotericin A Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCCC=CC=CC(C)C(O)C(C)C(C)OC(=O)CC(O)CC(O)CCC(O)C(O)CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 QGGFZZLFKABGNL-UHFFFAOYSA-N 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000012657 Atopic disease Diseases 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- DEELSAGAISLZBL-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCC(OO)=O.Cl Chemical compound CCCCCCCCCCCCCCCCCC(OO)=O.Cl DEELSAGAISLZBL-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 241000499489 Castor canadensis Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000206576 Chondrus Species 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 229930105110 Cyclosporin A Natural products 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000002656 Distearyl thiodipropionate Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 229920003134 Eudragit® polymer Polymers 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 241000208680 Hamamelis mollis Species 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical class O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000011779 Menyanthes trifoliata Nutrition 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 241001134446 Niveas Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 description 1
- GWFGDXZQZYMSMJ-UHFFFAOYSA-N Octadecansaeure-heptadecylester Natural products CCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC GWFGDXZQZYMSMJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000282372 Panthera onca Species 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- 208000002141 Pellagra Diseases 0.000 description 1
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 description 1
- 241000101040 Pityriasis Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- ARCJQKUWGAZPFX-KBPBESRZSA-N S-trans-stilbene oxide Chemical compound C1([C@H]2[C@@H](O2)C=2C=CC=CC=2)=CC=CC=C1 ARCJQKUWGAZPFX-KBPBESRZSA-N 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000320380 Silybum Species 0.000 description 1
- 235000010841 Silybum marianum Nutrition 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 239000003490 Thiodipropionic acid Substances 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- HEAHZSUCFKFERC-IWGRKNQJSA-N [(2e)-2-[[4-[(e)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical group CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C\C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-IWGRKNQJSA-N 0.000 description 1
- SZAMSYKZCSDVBH-CLFAGFIQSA-N [(z)-octadec-9-enyl] (z)-docos-13-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCC\C=C/CCCCCCCC SZAMSYKZCSDVBH-CLFAGFIQSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 1
- 229960002916 adapalene Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940024113 allethrin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229940009444 amphotericin Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- 229960004574 azelastine Drugs 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 208000027687 belching Diseases 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- DODLBEDXTHPKOW-UHFFFAOYSA-N bis(2,3-dihydroxypropyl) butanedioate Chemical compound OCC(O)COC(=O)CCC(=O)OCC(O)CO DODLBEDXTHPKOW-UHFFFAOYSA-N 0.000 description 1
- UFVWHIGSVGIZRQ-UHFFFAOYSA-N bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate Chemical compound C1=C(C(=O)OCC(CC)CCCC)C=CC2=CC(C(=O)OCC(CC)CCCC)=CC=C21 UFVWHIGSVGIZRQ-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 229960000962 bufexamac Drugs 0.000 description 1
- MXJWRABVEGLYDG-UHFFFAOYSA-N bufexamac Chemical compound CCCCOC1=CC=C(CC(=O)NO)C=C1 MXJWRABVEGLYDG-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940110975 butyloctyl benzoate Drugs 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 1
- 229910000421 cerium(III) oxide Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 125000000068 chlorophenyl group Chemical group 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 208000030381 cutaneous melanoma Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 230000001085 cytostatic effect Effects 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 150000001983 dialkylethers Chemical class 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- FDATWRLUYRHCJE-UHFFFAOYSA-N diethylamino hydroxybenzoyl hexyl benzoate Chemical compound CCCCCCOC(=O)C1=CC=CC=C1C(=O)C1=CC=C(N(CC)CC)C=C1O FDATWRLUYRHCJE-UHFFFAOYSA-N 0.000 description 1
- 229960001673 diethyltoluamide Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- FBSAITBEAPNWJG-UHFFFAOYSA-N dimethyl phthalate Natural products CC(=O)OC1=CC=CC=C1OC(C)=O FBSAITBEAPNWJG-UHFFFAOYSA-N 0.000 description 1
- 229960001826 dimethylphthalate Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- 235000019305 distearyl thiodipropionate Nutrition 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosanyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 1
- DLAHAXOYRFRPFQ-UHFFFAOYSA-N dodecyl benzoate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC=CC=C1 DLAHAXOYRFRPFQ-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003747 ecamsule Drugs 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000004872 foam stabilizing agent Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 208000024386 fungal infectious disease Diseases 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical compound O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
- 229960004675 fusidic acid Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Polymers 0.000 description 1
- 229940074052 glyceryl isostearate Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- RAMRROOXFMYSNA-UHFFFAOYSA-N hexadecyl benzoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1 RAMRROOXFMYSNA-UHFFFAOYSA-N 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 229960004716 idoxuridine Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 229960005280 isotretinoin Drugs 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 239000004922 lacquer Substances 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960001120 levocabastine Drugs 0.000 description 1
- ZCGOMHNNNFPNMX-KYTRFIICSA-N levocabastine Chemical compound C1([C@@]2(C(O)=O)CCN(C[C@H]2C)[C@@H]2CC[C@@](CC2)(C#N)C=2C=CC(F)=CC=2)=CC=CC=C1 ZCGOMHNNNFPNMX-KYTRFIICSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229940100573 methylpropanediol Drugs 0.000 description 1
- MJVGBKJNTFCUJM-UHFFFAOYSA-N mexenone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(C)C=C1 MJVGBKJNTFCUJM-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- OZGNYLLQHRPOBR-DHZHZOJOSA-N naftifine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)C\C=C\C1=CC=CC=C1 OZGNYLLQHRPOBR-DHZHZOJOSA-N 0.000 description 1
- 229960004313 naftifine Drugs 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- NKBWPOSQERPBFI-UHFFFAOYSA-N octadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCCCC NKBWPOSQERPBFI-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940120511 oleyl erucate Drugs 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 229940098695 palmitic acid Drugs 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940031709 peg-30-dipolyhydroxystearate Drugs 0.000 description 1
- 229960001179 penciclovir Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001281 polyalkylene Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229940048845 polyglyceryl-3 diisostearate Drugs 0.000 description 1
- 229920000232 polyglycine polymer Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- DQAKJEWZWDQURW-UHFFFAOYSA-N pyrrolidonecarboxylic acid Chemical compound OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 239000000741 silica gel Chemical group 0.000 description 1
- 229910002027 silica gel Chemical group 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000002884 skin cream Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 201000003708 skin melanoma Diseases 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229940080313 sodium starch Drugs 0.000 description 1
- RMLUKZWYIKEASN-UHFFFAOYSA-M sodium;2-amino-9-(2-hydroxyethoxymethyl)purin-6-olate Chemical compound [Na+].O=C1[N-]C(N)=NC2=C1N=CN2COCCO RMLUKZWYIKEASN-UHFFFAOYSA-M 0.000 description 1
- 239000002047 solid lipid nanoparticle Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940102548 stearalkonium hectorite Drugs 0.000 description 1
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- ARCJQKUWGAZPFX-UHFFFAOYSA-N stilbene oxide Chemical compound O1C(C=2C=CC=CC=2)C1C1=CC=CC=C1 ARCJQKUWGAZPFX-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229960004306 sulfadiazine Drugs 0.000 description 1
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 150000003458 sulfonic acid derivatives Chemical class 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960000565 tazarotene Drugs 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 235000019303 thiodipropionic acid Nutrition 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 239000010496 thistle oil Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 229940121343 tricaprilin Drugs 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- GKAVWWCJCPVMNR-UHFFFAOYSA-N tridecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCC GKAVWWCJCPVMNR-UHFFFAOYSA-N 0.000 description 1
- OYOGCAUNFUJOMO-UHFFFAOYSA-N trimethyl(octyl)silane Chemical compound CCCCCCCC[Si](C)(C)C OYOGCAUNFUJOMO-UHFFFAOYSA-N 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000002544 virustatic Substances 0.000 description 1
- 230000001790 virustatic effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229940118846 witch hazel Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Preparado cosmético y/o dermatológico a base de una emulsión Ag/Ac en forma de bolas o esferoides estables y/o rígidos, semirígidos a una temperatura de 35ºC con un volumen de 0,1 hasta 20 ml que contienen básicamente lípidos, emulgentes, polímeros naturales y/o sintéticos y/o mezclas de los mismos, que se caracteriza porque el preparado consta de una mezcla estable en forma de lípido/emulgente, el agua dispersada con un tamaño de gotas inferior a 50 micrómetros.Cosmetic and / or dermatological preparation based on an Ag / Ac emulsion in the form of stable and / or rigid balls or spheroids, semi-rigid at a temperature of 35 ° C with a volume of 0.1 to 20 ml containing basically lipids, emulsifiers, polymers natural and / or synthetic and / or mixtures thereof, characterized in that the preparation consists of a stable mixture in the form of a lipid / emulsifier, the water dispersed with a droplet size of less than 50 micrometers.
Description
La presente invención incluye un preparado cosmético o dermatológico para la aplicación tópica a base de una emulsión anhidra en forma de bolas estables y/o rígidas, semirígidas, esferoides o bien otros cuerpos con una forma determinada que contengan básicamente ceras, emulgentes, polímeros y/o mezclas sintéticas y/o naturales. El preparado se funde al ser extendido frotando la piel y/o el cabello y/o debido a las fuerzas de cizalladura se mezcla total o parcialmente con los lípidos del sebo cutáneo y/o se disuelve en 5 ellos. The present invention includes a cosmetic or dermatological preparation for topical application based on an anhydrous emulsion in the form of stable and / or rigid balls, semi-rigid, spheroids or other bodies with a specific shape that basically contain waxes, emulsifiers, polymers and / or synthetic and / or natural mixtures. The preparation is melted when it is extended by rubbing the skin and / or hair and / or due to the shear forces, it is mixed totally or partially with the lipids of the cutaneous sebum and / or dissolved in 5 of them.
Los comprimidos para la aplicación farmacéutica peroral se conocen desde como más tarde el siglo 19. Se trata por tanto de formas farmacéuticas rígidas monodosis que se han formado a partir de polvos secos, cristales o granulados bajo una presión elevada y en presencia de sustancias auxiliares (Rudolf Voigt.”Pharmazautische Technologie”; Deutsche Apotheker Verlag, Stuttgart, 9, Edición (2000). pág 163 ff.) 10 Tablets for peroral pharmaceutical application have been known since the late 19th century. They are therefore single dose rigid pharmaceutical forms that have been formed from dry powders, crystals or granules under high pressure and in the presence of auxiliary substances ( Rudolf Voigt. ”Pharmazautische Technologie”; Deutsche Apotheker Verlag, Stuttgart, 9, Edition (2000). P 163 ff.) 10
También se utilizan desde hace tiempo supositorios para aplicación rectal o vaginal. Se trata de preparados de forma estable, que se funden a la temperatura del cuerpo o bien se disuelven lentamente en un medio acuoso (2000), pág 267 ff.). Se pueden fabricar por compresión o fundición. Según el método de fabricación se ajustan además de los requisitos farmacéuticos convencionales como una buena tolerancia y compatibilidad con el principio activo otros requisitos en las materias primas empleadas como, por ejemplo, 15 pequeñas diferencias entre el punto de fusión y la temperatura de solidificación así como entre el punto de fluidez y la temperatura de fusión de un líquido transparente y al menos la estabilidad cinética de la modificación cristalina que se forma primero. No se han descrito hasta el momento supositorios para aplicación tópica. Suppositories for rectal or vaginal application have also been used for some time. These are stably preparations, which melt at body temperature or dissolve slowly in an aqueous medium (2000), p. 267 ff.). They can be manufactured by compression or casting. According to the manufacturing method, other requirements in the raw materials used are adjusted in addition to the conventional pharmaceutical requirements such as good tolerance and compatibility with the active ingredient, for example, 15 small differences between the melting point and the solidification temperature as well as between the pour point and the melting temperature of a transparent liquid and at least the kinetic stability of the first crystalline modification. Suppositories for topical application have not been described so far.
De la técnica actual se conocen además las cápsulas farmacéuticas, por ejemplo, cápsulas de 20 gelatina duras o blandas, que constan de una cubierta de gelatina y glicerina así como de posibles colorantes, y un relleno líquido, pastoso o de partículas. El método para la fabricación de estas cápsulas conocidas desde hace muchos años se rige según el llamado sistema Rotary-Die (Seifen-Öle-Fette-Wasche, 113, Jg;Nr 3/1987, página 67 ff.) Estas cápsulas de gelatina se disuelven al ser ingeridas en el tracto gastrointestinal y liberar su contenido. Puesto que es posible fabricar cápsulas de distintos tamaños y formas, su utilización no solamente 25 se limita a formas de aplicación perorales ((Rudolf Voigt.”Pharmazautische Technologie”; Deutsche Apotheker Verlag, Stuttgart, 9, Edición (2000). pág 543 ff.). Se puede lograr una resorción oral mediante cápsulas que se chupan. Por dentro son huecas y poseen un grosor de pared tres veces mayor que otras cápsulas. El principio activo se incorpora en este caso en la cubierta de gelatina. Otro ejemplo son las cápsulas de masticar de nitroglicerina (cápsulas que se rompen con los dientes) que facilitan asimismo una rápida resorción del 30 principio activo por la mucosa bucal. Además los medicamentos monodosis se pueden ingerir tras pinchar o cortar las cápsulas en forma de tubo aplastando hacia fuera el contenido para su aplicación (aplicación percutánea del bálsamo de nitroglicerina). Pharmaceutical capsules, for example, hard or soft gelatin capsules, consisting of a cover of gelatin and glycerin as well as possible colorants, and a liquid, pasty or particulate filler are also known from the current art. The method for manufacturing these capsules known for many years is governed by the so-called Rotary-Die system (Seifen-Öle-Fette-Wasche, 113, Jg; Nr 3/1987, page 67 ff.) These gelatin capsules are Dissolve when ingested in the gastrointestinal tract and release its contents. Since it is possible to manufacture capsules of different sizes and shapes, their use is not only limited to peroral application forms ((Rudolf Voigt. "Pharmazautische Technologie"; Deutsche Apotheker Verlag, Stuttgart, 9, Edition (2000). P 543 ff .) An oral resorption can be achieved by means of sucking capsules, inside they are hollow and have a wall thickness three times greater than other capsules.The active ingredient is incorporated in this case in the gelatin cover. Nitroglycerin chew capsules (capsules that break with the teeth) that also facilitate a rapid resorption of the active principle by the oral mucosa.In addition, the single-dose medications can be ingested after puncturing or cutting the capsules in the form of a tube by crushing out the content for application (percutaneous application of nitroglycerin balm).
Del sector de la alimentación se conocen, por ejemplo, distintos preparados sólidos a temperatura ambiente, que se funden a la temperatura del cuerpo. Se trata mayoritariamente de preparados a base de 35 grasa vegetal, en particular a base de manteca de caco así como de manteca de Karité (Sheabutter) (Chocolate) o bien emulsiones de agua/aceite a base de grasas vegetales endurecidas y ácidos grasos libres (margarina). Se conocen también los preparados llamados “bombón helado”, en los cuales debe aplicarse una entalpía de fusión elevada y tienen un efecto de frío en la boca. From the food sector, for example, various solid preparations are known at room temperature, which melt at body temperature. These are mostly preparations based on vegetable fat, in particular based on cocoa butter as well as Shea butter (Chocolate) or water / oil emulsions based on hardened vegetable fats and free fatty acids ( margarine). Preparations called "ice cream" are also known, in which a high enthalpy of fusion must be applied and have a cold effect on the mouth.
En el sector de la cosmética se habla de las llamadas perlas para el baño cuya cubierta, por ejemplo, 40 de gelatina se disuelve sin dejar residuos en un baño de agua caliente o fría y su contenido, por ejemplo, preparados tensoactivos, emulsiones, lípidos, colorantes y/o perfumes, se libera en el baño de agua. Puesto que la cubierta consta de gelatina, el producto no debe contener agua pues de lo contrario la cubierta se ablandaría durante el almacenamiento. In the cosmetics sector, the so-called pearls for the bath are discussed, whose cover, for example, 40 gelatin dissolves without leaving residues in a hot or cold water bath and its contents, for example, surfactant preparations, emulsions, lipids , dyes and / or perfumes, is released in the water bath. Since the cover consists of gelatin, the product should not contain water because otherwise the cover would soften during storage.
Un segundo grupo de cápsulas cosméticas engloba todos los productos para los cuales la cubierta 45 de la cápsula solamente equivale a un recipiente para una monodosis y su aplicación y cuya cubierta tras el uso sobra. El inconveniente es que la cubierta que sobra estorba y se debe eliminar. A second group of cosmetic capsules encompasses all products for which the cover 45 of the capsule is only equivalent to a container for a single dose and its application and whose cover after use is left over. The drawback is that the excess cover hinders and must be removed.
Numerosas sustancias activas cosméticas y/o dermatológicas no son estables frente a determinadas influencias como la humedad, los valores bajos o altos del pH o la luz. Por ello no faltan ensayos para intentar eliminar las mencionadas influencias ambientales no deseadas en este tipo de sustancias, pero sin embargo 50 siempre se produce una liberación de principio activo. Una forma de evitarlo será el micro- o macroencapsulado de las sustancias activas. El material de encapsulado como sistema soporte para la sustancia activa permite que ésta se pueda incorporar a los preparados adecuados protegida de los efectos ambientales, sin que el usuario tenga que hacerse cargo o aprovechar las cápsulas en la aplicación del producto. 55 Numerous cosmetic and / or dermatological active substances are not stable against certain influences such as humidity, low or high pH or light. Therefore, there is no lack of trials to try to eliminate the aforementioned undesirable environmental influences in this type of substances, but nevertheless there is always an active substance release. One way to avoid it will be the micro- or macroencapsulation of the active substances. The encapsulated material as a support system for the active substance allows it to be incorporated into the appropriate preparations protected from environmental effects, without the user having to take over or take advantage of the capsules in the application of the product. 55
Un objetivo de dicho encapsulado es, por ejemplo, fabricar partículas de cera que contengan sustancia activa de una magnitud de micrómetros (1-250 µm), que se puedan incorporar a los preparados cosméticos pastosos o líquidos. Por el momento no se sabe como fabricar estas microcápsulas como preparado cosmético independiente o autónomo, ni como almacenarlas y emplearlas por vía tópica. An objective of said encapsulation is, for example, to manufacture wax particles containing active substance of a magnitude of micrometers (1-250 µm), which can be incorporated into pasty or liquid cosmetic preparations. At the moment it is not known how to manufacture these microcapsules as an independent or autonomous cosmetic preparation, nor how to store and use them topically.
Para el encapsulado de las sustancias activas cosméticas existen varios enfoques o planteamientos. 5 Por ejemplo, se sabe que el encapsulado liposomal de productos farmacéuticos, puede llevar a una liberación retardada del principio activo. Básicamente se trata de una vesícula esférica que contiene principio activo rodeada de fosfolípidos o bien otros anfífilos, los llamados liposomas. No obstante, la estabilidad a largo plazo de este tipo de configuraciones es baja. For the encapsulation of cosmetic active substances there are several approaches or approaches. 5 For example, it is known that liposomal encapsulation of pharmaceutical products can lead to a delayed release of the active substance. Basically it is a spherical vesicle that contains active substance surrounded by phospholipids or other amphiphiles, the so-called liposomes. However, the long-term stability of this type of configuration is low.
Las nanopartículas son partículas sólidas con unos tamaños de partícula entre 20 y 500 nm. 10 Ocasionalmente se calculan también partículas más grandes con diámetros de hasta 1000 nm para las nanopartículas. Este tipo de partículas se componen generalmente de polímeros y presentan cavidades o bien forman una cubierta, de manera que en su interior pueden conservar moléculas huésped, que son adsorbidas o encerradas. Estas moléculas huésped son liberadas lentamente al utilizar el producto que contiene las nanopartículas. De un modo similar se comportan las nanopartículas lipídicas sólidas, que 15 contienen en una matriz sustancias activas distribuidas en los lípidos sólidos. El tamaño de las partículas es comparable al de las nanopartículas. The nanoparticles are solid particles with particle sizes between 20 and 500 nm. 10 Occasionally, larger particles with diameters of up to 1000 nm are also calculated for the nanoparticles. These types of particles are generally composed of polymers and have cavities or form a shell, so that inside they can retain host molecules, which are adsorbed or enclosed. These host molecules are released slowly when using the product that contains the nanoparticles. In a similar way, solid lipid nanoparticles behave, which contain active substances distributed in solid lipids in a matrix. The particle size is comparable to that of the nanoparticles.
Para el encapsulado de los principios o sustancias activas farmacéuticas o cosméticas para el control de la liberación de las sustancias activas o de la incorporación estable en los preparados se conocen numerosos métodos. 20 Numerous methods are known for the encapsulation of the pharmaceutical or cosmetic active ingredients or substances for the control of the release of the active substances or of the stable incorporation into the preparations. twenty
La patente europea EP064911 o bien EP1064912 informa sobre microcápsulas que contienen principios activos, con un diámetro de 0,1 a 5 mm, de manera que se fabrica una matriz compuesta de formadores de gel, quitosano y principio activo, y ésta se instila en soluciones acuosas de polímeros aniónicos. Con ello se forma una membrana a base de quitosano y polímero aniónico, que rodea o envuelve la solución de principio activo. Estas micropartículas se emplean luego de nuevo como componente de los 25 preparados cosméticos convencionales. En general sobre las técnicas de encapsulado con quitosano se informa en Journal of Microencapsulation 14, páginas 689-711 (1997). European patent EP064911 or EP1064912 reports microcapsules containing active ingredients, with a diameter of 0.1 to 5 mm, so that a matrix composed of gel-forming, chitosan and active ingredient is manufactured, and this is instilled in solutions aqueous anionic polymers. This forms a membrane based on chitosan and anionic polymer, which surrounds or wraps the active ingredient solution. These microparticles are then used again as a component of the conventional cosmetic preparations. In general, chitosan encapsulation techniques are reported in the Journal of Microencapsulation 14, pages 689-711 (1997).
Se conocen las sustancias activas mayoritariamente lipófilas, encapsuladas a base de partículas lipídicas. Así las patentes EP 167825, DE 100 59 668, DE 199 45 203, EP 0934743, WO 94/20072, WO 00/10522 así como la WO 00/67728 describen partículas lipídicas cargadas de sustancias activas. Estos 30 documentos no han podido solucionar el problema de la preparación de preparados o compuestos de forma esférica con o sin sustancia cosméticas, que se puedan fabricar como un preparado cosmético independiente, el cual se pueda almacenar y aplicar por vía tópica. The mostly lipophilic active substances, encapsulated based on lipid particles, are known. Thus, patents EP 167825, DE 100 59 668, DE 199 45 203, EP 0934743, WO 94/20072, WO 00/10522 as well as WO 00/67728 describe lipid particles loaded with active substances. These 30 documents have not been able to solve the problem of preparing preparations or compounds spherically with or without cosmetic substances, which can be manufactured as an independent cosmetic preparation, which can be stored and applied topically.
A temperatura ambiente las barritas sólidas protectoras de los labios a base de emulsiones de Ag/Ac se han descrito en la DE 10148313. Esta tecnología allí descrita es el objeto de la presente invención. Las 35 emulsiones conforme a la DE 10148313 que se frotan o esparcen por la piel no son líquidas y únicamente queda una abrasión de la emulsión en la zona aplicada, especialmente en los labios. No se desea una licuación de los preparados descritos, puesto que para el cuidado de los labios el material que se aplica a ser posible se mantiene en el lugar de aplicación durante largo tiempo y no debe salir volando. At room temperature, the solid protective bars of the lips based on Ag / Ac emulsions have been described in DE 10148313. This technology described therein is the object of the present invention. The emulsions according to DE 10148313 that are rubbed or scattered on the skin are not liquid and only an abrasion of the emulsion remains in the applied area, especially on the lips. A liquefaction of the described preparations is not desired, since for the care of the lips the material that is applied if possible is kept in the place of application for a long time and should not fly away.
El cometido de la presente invención es por tanto conseguir un preparado cosmético que se presente 40 como una bola estable en forma que se pueda aplicar a la piel como una sola pieza. Por lo que no debe dejar residuos, material de la cápsula etc...que deban ser eliminados de forma especial o que queden visibles sobre la piel. En particular el cometido de la presente invención es conseguir un preparado cosmético que corresponda a una nueva forma de producto cosmético y ofrezca al usuario un nuevo campo o experiencia de aplicación y amplíe el espectro de aplicación de los productos para el cuidado de la piel y/o del cabello. 45 The purpose of the present invention is therefore to achieve a cosmetic preparation that is present as a stable ball so that it can be applied to the skin as a single piece. So you should not leave residues, capsule material etc ... that must be removed in a special way or that are visible on the skin. In particular, the purpose of the present invention is to achieve a cosmetic preparation that corresponds to a new form of cosmetic product and offers the user a new field or application experience and broadens the application spectrum of skin care products and / or hair Four. Five
Todo esto se consigue mediante un preparado cosmético que cumpla las reivindicaciones principales. En las subreivindicaciones se informa sobre las configuraciones preferidas del preparado. La invención incluye además el método para la aplicación del preparado sobre la piel y/o sobre el cabello, la utilización y la combinación con un envase alveolar o blister y cajitas. All this is achieved by a cosmetic preparation that meets the main claims. The preferred claims of the preparation are reported in the subclaims. The invention also includes the method for the application of the preparation on the skin and / or on the hair, the use and the combination with an alveolar or blister pack and boxes.
Ha sorprendido en particular al experto que los cometidos planteados se hayan resuelto por medio 50 de un preparado cosmético y/o dermatológico a base de una emulsión Ag/Ac en forma de bolas o esferoides estables en forma y/o rígidos, semirígidos a una temperatura de 35º, con un volumen de 0,1 hasta 20 ml, que contienen básicamente ceras, lípidos, emulgentes, polímeros naturales y/o sintéticos y/o mezclas de los mismos, de manera que el preparado consta de una mezcla de lípido/emulgente estable en forma, que contiene agua dispersada con un tamaño de gotas inferior a 50 micrómetros. Por debajo de las condiciones 55 de almacenamiento, es decir, a una temperatura inferior a la temperatura ambiente, los preparados son total o parcialmente sólidos. The expert has been particularly surprised that the proposed tasks have been solved by means of a cosmetic and / or dermatological preparation based on an Ag / Ac emulsion in the form of balls or spheroid stable and / or rigid, semi-rigid at a temperature 35º, with a volume of 0.1 to 20 ml, which basically contain waxes, lipids, emulsifiers, natural and / or synthetic polymers and / or mixtures thereof, so that the preparation consists of a mixture of lipid / emulsifier stable in shape, containing dispersed water with a droplet size of less than 50 micrometers. Below storage conditions, that is, at a temperature below room temperature, the preparations are totally or partially solid.
La ventaja y al mismo tiempo la característica conforme a la invención del preparado en forma de cápsula es que The advantage and at the same time the characteristic according to the invention of the capsule preparation is that
- - al restregar y/o distribuir la cápsula por la piel y/o el cabello ésta se funde y/o - when scrubbing and / or distributing the capsule through the skin and / or hair it melts and / or
- - debido a las fuerzas de cizalladura se licúa total o parcialmente y/o - due to the shear forces, it is totally or partially liquefied and / or
- - se disuelve en el relleno y/o los lípidos del sebo cutáneo o bien mezclándose con el 5 relleno y el material de la cubierta - it dissolves in the filler and / or the skin sebum lipids or by mixing with the filler and the cover material
y de esta forma no es perceptible por el usuario, como algo especial distinto del relleno del propio preparado. and in this way it is not perceptible by the user, as something special other than the filling of the preparation itself.
Es decir, preferiblemente en la aplicación sobre la piel o el cabello la cápsula se desprende totalmente si dejar residuos. That is, preferably in the application on the skin or hair the capsule is completely detached if leaving residues.
Frente a las cápsulas cosméticas conocidas, cuya cubierta queda tras la aplicación, la bola aquí descrita es 10 totalmente diferente. Por tanto, toda la bola constituye una contribución o aporte activo para el cuidado de la piel y/o cabello en el preparado cosmético y dermatológico. Se puede recurrir a muchos términos como “bolas” o “cápsulas” para describir el preparado conforme a la invención, pero estos términos según las circunstancias tienen significados distintos. Así los términos “Bombones” o “supositorio” son realmente poco cosméticos. 15 Compared to the known cosmetic capsules, whose cover is after application, the ball described here is totally different. Therefore, the entire ball constitutes an active contribution or contribution for the care of the skin and / or hair in the cosmetic and dermatological preparation. Many terms such as "balls" or "capsules" can be used to describe the preparation according to the invention, but these terms according to the circumstances have different meanings. Thus the terms "Chocolate" or "suppository" are really not very cosmetic. fifteen
Unamos los tipos de aplicación. El término “bola” o “cápsula” para describir el preparado conforme a la invención no se limita a su significado matemático, sino que engloba todo cuerpo exacto o aproximadamente regular o irregular, en forma de bola, esféricos, redondos, ovalados, elipsoides, así como aquellos con esquinas y cantos, como, por ejemplo, paralepípedos, cuadrados, estrellas, corazones, cubos y similares. Let's join the types of application. The term "ball" or "capsule" to describe the preparation according to the invention is not limited to its mathematical meaning, but encompasses any exact or approximately regular or irregular body, ball-shaped, spherical, round, oval, ellipsoid, as well as those with corners and edges, such as parallelepipeds, squares, stars, hearts, cubes and the like.
El preparado conforme a la invención engloba productos cosméticos previamente distribuidos en 20 dosis, estables en forma, a temperatura ambiente (RT), los cuales al frotar y/o distribuirse por la piel y/o el cabello, se funden o licúan o bien se disuelve. Con ello se garantiza que el cosmético se puede aplicar sobre la piel o el cabello sin dejar residuos molestos. The preparation according to the invention encompasses cosmetic products previously distributed in 20 doses, stable in form, at room temperature (RT), which when rubbed and / or distributed through the skin and / or hair, melt or liquefy or else dissolves This ensures that the cosmetic can be applied to the skin or hair without leaving annoying residue.
Frente a los preparados en forma de cápsula conocidos actualmente no queda ningún residuo material sin aprovechar sobre la piel, que pueda ser visible y que de lugar a gastos innecesarios y cargas 25 ambientales ya que sea preciso su eliminación por el usuario tras la aplicación del producto. Los preparados conocidos en la actualidad que no tienen forma de cápsula como el chocolate o los supositorios no son adecuados para la aplicación tópica, ya que en primer lugar presentan una temperatura de fusión poco adecuada (la temperatura de la piel se sitúa esencialmente por debajo de la temperatura normal del cuerpo) y en segundo lugar no se pueden aplicar frotando. En tercer lugar no se trata de emulsiones (a excepción de la 30 margarina) y al faltar el agua producen en la piel una sensación desagradable, nada cosmética. Por ejemplo, en el caso de la margarina una falta de estabilidad de forma durante el almacenamiento impide una aplicación en el sentido de la presente invención. In the face of the capsule preparations currently known, there is no material residue left unused on the skin, which may be visible and that leads to unnecessary expenses and environmental charges since its elimination by the user is necessary after the application of the product . Preparations known today that have no capsule form such as chocolate or suppositories are not suitable for topical application, since they first have a poor melting temperature (the skin temperature is essentially below normal body temperature) and secondly they cannot be applied by rubbing. Thirdly, it is not about emulsions (with the exception of 30 margarine) and when the water is lacking they produce an unpleasant sensation on the skin, nothing cosmetic. For example, in the case of margarine, a lack of form stability during storage prevents an application within the meaning of the present invention.
Las bolas conforme a la invención presentan un tamaño, es decir, un diámetro medio, entre 3 y 40 mm. Los preparados conforme a la invención pueden tener cualquier tipo de forma. Sin embargo, son 35 esféricos con un volumen entre 0,1 y 20 ml. Por tanto las bolas se pueden aplicar y manejar por si solas. Los preparados son estables en forma como grageas, bolas, esferoides, elipsoides o bien otros cuerpos, durante el almacenamiento y la extracción del envoltorio y al frotar y restregar la piel y/o el cabello se licúan. Esto se consigue, por ejemplo, mediante la composición especial de la fase lipídica de la emulsión Ag/Ac. The balls according to the invention have a size, that is, an average diameter, between 3 and 40 mm. The preparations according to the invention can have any type of shape. However, they are spherical with a volume between 0.1 and 20 ml. Therefore the balls can be applied and handled by themselves. The preparations are stable in form such as dragees, balls, spheroids, ellipsoids or other bodies, during storage and removal of the wrapper and when rubbing and scrubbing the skin and / or hair are liquefied. This is achieved, for example, by the special composition of the lipid phase of the Ag / Ac emulsion.
El preparado en forma de bola conforme a la invención debe ser rígido y estable en forma en las 40 condiciones de almacenamiento a las que normalmente están expuestos sus productos cosméticos, es decir, la forma de las bolas conforme a la invención no puede verse alterada durante el almacenamiento ni por la acción de la gravitación o la temperatura hasta los 35ºC. De un modo ideal las bolas no se pegan durante el almacenamiento, incluso cuando dos bolas se tocan durante mucho tiempo. En su caso es preferible forrar cada una de las bolas de una cubierta que mejore la estabilidad de la forma, evite o disminuya el pegado de 45 cada una de las bolas y/o reduzca o impida la pérdida de peso por la evaporación de agua y/o otros componentes fácilmente volátiles. The ball-shaped preparation according to the invention must be rigid and stable in shape in the storage conditions to which its cosmetic products are normally exposed, that is, the shape of the balls according to the invention cannot be altered during storage or by the action of gravitation or temperature up to 35 ° C. Ideally, the balls do not stick during storage, even when two balls touch each other for a long time. Where appropriate, it is preferable to line each of the balls of a cover that improves the stability of the shape, prevents or decreases the bonding of each of the balls and / or reduces or prevents weight loss by evaporation of water and / or other easily volatile components.
El material de la bola del compuesto conforme a la invención queda totalmente sobre la piel sin dejar residuos insignificantes. El preparado conforme a la invención tien por tanto las propiedades preferidas de la conocida crema, loción cosmética etc. Tiene una gran importancia que todas las materias primas, a partir de 50 las cuales se construye la bola, sean realmente bien toleradas por la piel. Idealmente contribuyen al cuidado de la piel de manera que refuerzan las barreras naturales de la piel y la protegen de la sequedad. The ball material of the compound according to the invention is completely on the skin without leaving insignificant residues. The preparation according to the invention therefore has the preferred properties of the known cream, cosmetic lotion etc. It is of great importance that all raw materials, from 50 of which the ball is constructed, are really well tolerated by the skin. Ideally they contribute to skin care so that they reinforce the skin's natural barriers and protect it from dryness.
La composición de la bola influye además notablemente en la sensación cutánea del usuario al The composition of the ball also has a significant influence on the user's skin sensation at
aplicar el producto conforme a la invención. Por tanto es preferible que la bola se componga de aquellas sustancias que aporten una sensación agradable. apply the product according to the invention. Therefore it is preferable that the ball is composed of those substances that provide a pleasant sensation.
Los requisitos técnicos y sensoriales aquí descritos sobre el preparado conforme a la invención superan claramente el espectro convencional de uso de los preparados cosméticos conocidos. Por tanto es sorprendente de que el preparado conforme a la invención pueda fabricarse con materias primas como las que ya conocen los técnicos y ya se emplean en cosmética. The technical and sensory requirements described herein on the preparation according to the invention clearly exceed the conventional spectrum of use of known cosmetic preparations. It is therefore surprising that the preparation according to the invention can be manufactured with raw materials such as those already known to the technicians and are already used in cosmetics.
Se tienen en cuenta los principios siguientes. 5 The following principles are taken into account. 5
Por un lado, se pueden emplear lípidos, cuyo punto de fusión se aproxime a la temperatura de la piel de 32ºC, es decir entre 30ºC y 40ºC, para la fabricación de un preparado conforme a la invención. Por otro lado se puede fabricar un preparado tixotropo utilizando las ceras, el espesante polimérico y/o los formadores de geles adecuados a partir de sistemas lipídicos fluidos con un límite de fluidez elevado, que satisfaga los requisitos del preparado descrito. Para el experto es evidente que los preparados mencionados, el uso de 10 lípidos con puntos de fusión preferidos y el empleo de sistemas tixotrópicos con un límite de fluidez adecuado, se pueden combinar de cualquier manera para optimizar las propiedades de la preparación. On the one hand, lipids, whose melting point approaches the skin temperature of 32 ° C, that is between 30 ° C and 40 ° C, can be used for the manufacture of a preparation according to the invention. On the other hand, a thixotropic preparation can be manufactured using the waxes, the polymeric thickener and / or suitable gel-forming agents from fluid lipid systems with a high fluidity limit, which satisfies the requirements of the described preparation. It is clear to the expert that the aforementioned preparations, the use of 10 lipids with preferred melting points and the use of thixotropic systems with an adequate fluidity limit, can be combined in any way to optimize the properties of the preparation.
El preparado consta de una mezcla estable en forma de lípido/emulgente, que contiene el agua dispersada con un tamaño de partícula inferior a 50 micrómetros. The preparation consists of a stable mixture in the form of a lipid / emulsifier, which contains the dispersed water with a particle size of less than 50 micrometers.
Con ayuda de estas ventajas el experto puede ser capaz de ingeniárselas para fabricar un preparado 15 conforme a la invención. El preparado se caracteriza por tanto por que With the help of these advantages, the expert may be able to manage them to make a preparation according to the invention. The preparation is therefore characterized by the fact that
- - al frotarlo y/o esparcirlo por la piel y/o el cabello se funde y/o - when rubbing and / or spreading it through the skin and / or the hair melts and / or
- - gracias a las fuerzas de cizalladura es parcial o totalmente líquido y/o - thanks to the shear forces it is partially or totally liquid and / or
- - se mezcla con los lípidos del sebo cutáneo y/o se disuelve en ellos. - It is mixed with the lipids of the skin sebum and / or dissolved in them.
Conforme a la invención el cosmético se aplica sobre la piel y/o el cabello sin dejar residuo. Sin residuos 20 equivale a que visualmente no se pueden percibir residuos sobre la piel o en el cabello. According to the invention, the cosmetic is applied to the skin and / or hair without leaving any residue. Without residues 20 it is equivalent to that visually no residues can be perceived on the skin or in the hair.
Varias bolas conforme a la invención pueden ser almacenadas juntas en un envase a base de papel, metal o plástico, etc... por medio de unos envases delgados similares al papel del bombón o bien se almacenan por separado en un envase tipo blister. Several balls according to the invention can be stored together in a paper-based container, metal or plastic, etc ... by means of thin containers similar to the paper of the chocolate or stored separately in a blister pack.
En particular se prefiere la combinación de los preparados conforme a la invención con un envase 25 tipo blister, que durante el almacenamiento separa cada una de las bolas e impide que se junten unas con otras. Esto se puede conseguir envolviendo cada una de las bolas con una lámina fina de papel, metal o plástico. Además los preparados se pueden envasar en tubos, por ejemplo, de poliestireno, o en láminas. Se pueden emplear láminas de celofán, de aluminio y de papel así como de plástico. En general, el PE (grado de polimerización de 3000-4000) sirve de material para este tipo de envases. Otras posibilidades son los 30 envases a presión, en los cuales se emplea una lámina de plástico, por ejemplo, una lámina de aluminio sellada. Los preparados pueden, por ejemplo, ser colocados en cajas dobladas, cajas de cartón o hechuras de plástico. In particular, the combination of the preparations according to the invention with a blister pack 25 is preferred, which during storage separates each of the balls and prevents them from joining together. This can be achieved by wrapping each of the balls with a thin sheet of paper, metal or plastic. In addition, the preparations can be packaged in tubes, for example, of polystyrene, or in sheets. You can use sheets of cellophane, aluminum and paper as well as plastic. In general, PE (polymerization degree of 3000-4000) serves as a material for this type of packaging. Other possibilities are the 30 pressure containers, in which a plastic sheet is used, for example, a sealed aluminum sheet. The preparations can, for example, be placed in folded boxes, cardboard boxes or plastic casts.
La extracción de cada una de las bolas conforme a la invención puede realizarse de un modo simple con la mano. Las bolas presentan un tamaño manejable conforme a la invención. Pero también es posible 35 extraer fácilmente el preparado mediante un sistema dispensador adecuado. Por ejemplo, activando un simple mecanismo el sistema dispensador podrá liberar cada una de las bolas. Ejemplos de ello son los sistemas dispensadores para bombones y otros artículos dulces de la empresa PEZ International AG bajo la marca “PEZ”. The extraction of each of the balls according to the invention can be carried out in a simple way by hand. The balls have a manageable size according to the invention. But it is also possible to easily extract the preparation by means of a suitable dispensing system. For example, by activating a simple mechanism, the dispensing system can release each of the balls. Examples are the dispensing systems for chocolates and other sweet items of the company PEZ International AG under the brand "PEZ".
Pero también se prefieren los sistemas dispensadores en los cuales se almacenan en cavidades las 40 bolas de un disco redondo en forma helicoidal y se extraen individualmente mediante un mecanismo dosificador. Se prefieren especialmente aquellos modelos que por su forma externa recuerdan productos cosméticos conocidos, por ejemplo, el conocido bote de NIVEA, puesto que esto reduce el peligro de una equivocación con alimentos. But dispensing systems are also preferred in which the 40 balls of a helical round disk are stored in cavities and extracted individually by means of a metering mechanism. Especially preferred are those models that by their external form recall known cosmetic products, for example, the well-known NIVEA canister, since this reduces the danger of a mistake with food.
En la utilización se extraen cada una de las bolas y se frota la piel con ellas. El producto es poco 45 viscoso y se distribuye bien y se disuelve por la piel o el cabello, al fundirse, cuartearse o disolverse los componentes sólidos del producto. Para el experto resulta evidente que el preparado conforme a la invención puede contener componentes sólidos, los cuales se disolverán durante la aplicación, es decir sustancias sólidas como las que se emplean en los cosméticos convencionales, sin que importe la forma en que se encuentren. Ejemplos de ello son los materiales de relleno, los pigmentos colorantes y fotoprotectores. 50 In use, each of the balls is removed and the skin is rubbed with them. The product is not very viscous and is well distributed and dissolves through the skin or hair, when melting, cracking or dissolving the solid components of the product. It is clear to the expert that the preparation according to the invention may contain solid components, which will dissolve during application, that is, solid substances such as those used in conventional cosmetics, regardless of how they are found. Examples of this are fillers, dyes and photoprotective pigments. fifty
El usuario extrae una o varias bolas y frota la piel con ellas como lo haría con una crema para la piel procedente de un tubo. Sin embargo es preferible que el pueda emplear una cantidad previamente parcelada sin residuos y envase. The user removes one or several balls and rubs the skin with them as he would with a skin cream from a tube. However, it is preferable that he can use a previously parceled amount without waste and packaging.
La ventaja del preparado conforme a la invención es la aplicación individual simple, cómoda. Del mismo modo que se maquillan o engrasan los labios es posible aplicar una crema o cuidar la piel. Además el 5 usuario puede ofrecer algunas bolas a otros usuarios. Esto es ciertamente posible también en los productos cosméticos convencionales, pero el aprovechamiento común, por ejemplo, de una crema de un mismo tarro, se parece fisiológicamente a un contacto corporal. Por tanto aquí existe un umbral o barrera de inhibición, que se elimina mediante la presente invención. The advantage of the preparation according to the invention is the simple, comfortable individual application. In the same way that the lips are made up or greased it is possible to apply a cream or take care of the skin. In addition the 5 user can offer some balls to other users. This is certainly also possible in conventional cosmetic products, but the common use, for example, of a cream from the same jar, physiologically resembles body contact. Therefore there is a threshold or barrier of inhibition, which is eliminated by the present invention.
También es posible ofrecer en un envase las bolas conforme a la invención con distintas propiedades 10 (por ejemplo, perfume, color, sensación cutánea, factor fotoprotector, principios activos y combinaciones de estas propiedades, lo que no es posible con los productos para el cuidado de la piel convencionales. It is also possible to offer in a package the balls according to the invention with different properties 10 (for example, perfume, color, skin sensation, photoprotective factor, active ingredients and combinations of these properties, which is not possible with care products of conventional skin.
Otra ventaja es que el empleo de las bolas conforme a la invención es más divertido para algunos usuarios como los niños que el empleo del producto cosmético convencional. Esto puede facilitar a los padres la protección de sus hijos de las influencias ambientales peligrosas como, por ejemplo, la radiación UV. El 15 experto sabe que es un gran problema la protección de los productos cosméticos ante hongos, bacterias, gérmenes que durante el uso pasan al producto. Esto ocurre sobre todo cuando se agarra el producto durante el proceso de extracción. Es evidente que las bolas conforme a la invención tienen aquí otra ventaja, puesto que el usuario únicamente toca aquellas bolas que va a emplear inmediatamente. El resto de bolas se mantienen protegidas del ataque microbiano gracias a que en comparación con los productos cosméticos 20 convencionales, por cuyo motivo pueden ser manipuladas con contenidos inferiores en los medios de conservación, en comparación con los productos cosméticos convencionales. Puesto que los medios de conservación forman parte de las materias primas cosméticas menos toleradas, se consigue una mayor tolerancia del producto, lo que es otra ventaja de la presente invención. Another advantage is that the use of the balls according to the invention is more fun for some users like children than the use of the conventional cosmetic product. This can make it easier for parents to protect their children from dangerous environmental influences such as UV radiation. The expert knows that it is a big problem to protect cosmetic products against fungi, bacteria, germs that pass to the product during use. This occurs especially when the product is seized during the extraction process. It is clear that the balls according to the invention have another advantage here, since the user only touches those balls that he will use immediately. The rest of the balls are kept protected from microbial attack thanks to the fact that compared to conventional cosmetic products 20, for which reason they can be handled with lower contents in the preservation media, compared to conventional cosmetic products. Since the preservation media are part of the less tolerated cosmetic raw materials, greater product tolerance is achieved, which is another advantage of the present invention.
El preparado en forma de bola puede estar compuesto de ceras, grasas, aceites, aceites de silicona, 25 agua, glicerina y otros polioles, así como otros aditivos solubles en agua o en aceite. La bola tiene una estabilidad satisfactoria a los golpes, capaz de soportar las cargas mecánicas durante la fabricación y el almacenamiento, y es suficientemente delgada para poder distribuirse rápidamente por la piel en la aplicación. The ball-shaped preparation may be composed of waxes, greases, oils, silicone oils, water, glycerin and other polyols, as well as other water or oil soluble additives. The ball has satisfactory shock stability, capable of withstanding mechanical loads during manufacturing and storage, and is thin enough to be able to be quickly distributed through the skin in the application.
La fase lipídica de las bolas está formada preferiblemente por ceras como la ceresina, ozokerita, ceras a base de ésteres, ceras a base de glicéridos y/o alcoholes grasos así como emulgentes sólidos y sus 30 mezclas. Las ceras pueden ser, por su origen, ceras naturales, ceras naturales modificadas, ceras parcial o totalmente sintéticas. The lipid phase of the balls is preferably formed by waxes such as ceresin, ozokerite, waxes based on esters, waxes based on glycerides and / or fatty alcohols as well as solid emulsifiers and their mixtures. The waxes can be, by their origin, natural waxes, modified natural waxes, partially or totally synthetic waxes.
Todos los componentes se eligen de manera que garanticen la estabilidad requerida en cuanto a forma y temperatura, impidan el secado por evaporación y se fundan rápidamente en la aplicación, debido a su licuación parcial o total por las fuerzas de cizalladura o bien su disolución en el material de relleno. 35 All components are chosen to guarantee the required stability in terms of shape and temperature, prevent evaporation drying and quickly melt in the application, due to their partial or total liquefaction by shear forces or their dissolution in the Filling material. 35
Para optimizar las propiedades elásticas se pueden incorporar polímeros al preparado. Los polímeros apropiados son el éter de celulosa, la polivinilpirrolidona y sus derivados, poliacrilatos o polimetacrilatos, así como Eudragit. To optimize the elastic properties polymers can be incorporated into the preparation. Suitable polymers are cellulose ether, polyvinylpyrrolidone and its derivatives, polyacrylates or polymethacrylates, as well as Eudragit.
Las bolas conforme a la invención se componen preferiblemente de ceras procedentes del grupo de The balls according to the invention are preferably composed of waxes from the group of
- - ceras naturales, en particular la cera de Carnauba, cera de Candelila, cera de laca, cera de 40 bayas (Rhus Verniciflura), manteca de Karité (Butyrospermum Parkii), aceites vegetales hidratados, como el aceite de palma o de colza, cera de abejas, cera entera (Eucerit) - natural waxes, in particular Carnauba wax, Candelila wax, lacquer wax, 40 berry wax (Rhus Verniciflura), Shea butter (Butyrospermum Parkii), hydrated vegetable oils, such as palm or rapeseed oil, wax of bees, whole wax (Eucerit)
- - Mono-, Di- y triglicéridos de ácidos grasos altamente saturados con 10-30 átomos de carbono o bien mezclas de los mismos, en particular el tripalmitato de glicerilo (Dynasan 116) y/o estearato de glicerilo, tribehenato de glicerilo (Syncrowax HRC). 45 - Mono-, Di- and triglycerides of highly saturated fatty acids with 10-30 carbon atoms or mixtures thereof, in particular glyceryl tripalmitate (Dynasan 116) and / or glyceryl stearate, glyceryl tribehenate (Syncrowax HRC ). Four. Five
- - alcoholes grasos altamente saturados, en particular se prefieren aquellos con 14-30 átomos de carbono, en especial el alcohol estearílico y/o behenílico y/o cetílico - highly saturated fatty alcohols, in particular those with 14-30 carbon atoms, especially stearyl and / or behenyl and / or cetyl alcohol are preferred
- - éster sintético, preferiblemente el estearato de alquilhidroxiestearoilo C16-36, estearato de estearilo, behenato de cetearilo, estearato de alquilo C20-40, en particular, el palmitato de cetilo, palmitato de metilo, miristato de miristilo, ricinoleato de cetilo 50 - synthetic ester, preferably C16-36 alkylhydroxyetearoyl stearate, stearyl stearate, cetearyl behenate, C20-40 alkyl stearate, in particular, cetyl palmitate, methyl palmitate, myristyl myristate, cetyl ricinoleate 50
- - ceras poliméricas, preferiblemente el polietileno, polipropileno, éter de polivinilo, polideceno, en particular el éter de polivinilestearilo y el polideceno hidratado - polymeric waxes, preferably polyethylene, polypropylene, polyvinyl ether, polydecene, in particular polyvinyl stearyl ether and hydrated polydecene
- - copolímeros, preferiblemente los de acetato de etileno y de vinilo así como de - copolymers, preferably those of ethylene acetate and vinyl as well as
- polivinilpirrolidona y hexadeceno polyvinylpyrrolidone and hexadecene
- - hidrocarburos de carbono/ceras de parafina, en particular la Cera Microcristalina, Cera de parafina, Ceresina, Ozokerita - carbon hydrocarbons / paraffin waxes, in particular Microcrystalline Wax, Paraffin Wax, Ceresin, Ozokerite
- - Ceras de silicona - Silicone waxes
- - Ceras químicamente modificadas - Chemically modified waxes
- - cualquier mezcla de ceras de los grupos mencionados 5 - any mixture of waxes from the groups mentioned 5
Las ceras especialmente preferidas conforme a la invención para la fabricación del preparado conforme a la invención son el palmitato de cetilo, ricinoleato de cetilo, la cera de abeja, el cocoglicérido hidratado, palmitato de metilo, cera de Candelilla, cera de Carnauba, cera de parafina, ceresina, ozokerita, miristato de miristilo, tripalmitina, tribehenina, palmitoestearato de glicerilo, aceite de colza hidratado, y estearato de alquilestearilo C15-40. 10 Especially preferred waxes according to the invention for the preparation of the preparation according to the invention are cetyl palmitate, cetyl ricinoleate, beeswax, hydrated cocoglyceride, methyl palmitate, Candelilla wax, Carnauba wax, paraffin, ceresin, ozokerite, myristyl myristate, tripalmitin, tribehenin, glyceryl palmitosterate, hydrated rapeseed oil, and C15-40 alkyl stearyrate stearate. 10
Las bolas conforme a la invención pueden contener los aditivos o y sustancias auxiliares convencionales que son bien conocidas por el experto y que normalmente se emplean en cosmética. Por ejemplo, medios conservantes, bactericidas, sustancias con acción desodorante, antitranspirantes, repelentes de insectos, vitaminas, medios para evitar la espuma, colorantes, pigmentos con acción colorante, sustancias gustativas, desnaturalizantes, perfumes, espesantes, sustancias suavizantes, sustancias humectantes y/o que 15 contienen humedad, antioxidantes, sustancias filtro de rayos UV, adictivos sensoriales, formadores de películas, tensoactivos, emulgentes, grasas, aceites, ceras, principios activos o bien otros componentes habituales de una fórmula cosmética como los alcoholes, polioles, polímeros estabilizantes, estabilizadores de espuma, electrolitos, disolventes orgánicos o derivados de silicona. The balls according to the invention may contain the conventional additives and auxiliary substances that are well known to those skilled in the art and normally used in cosmetics. For example, preservatives, bactericides, substances with deodorant action, antiperspirants, insect repellents, vitamins, means to avoid foam, colorants, pigments with coloring action, taste substances, denaturing agents, perfumes, thickeners, softening substances, wetting substances and / or that contain moisture, antioxidants, UV filter substances, sensory additives, film formers, surfactants, emulsifiers, fats, oils, waxes, active ingredients or other common components of a cosmetic formula such as alcohols, polyols, stabilizing polymers , foam stabilizers, electrolytes, organic solvents or silicone derivatives.
COmo emulgentes de Ag/Ac preferidos se pueden emplear: alcoholes grasos con 8 hasta 30 átomos 20 de carbono, éster de monoglicerina de ácidos alcanocarboxílicos santurados y/o insaturados, ramificados o no ramificados de una longitud de cadena de 8 hasta 24, en particular de 12 hasta 20 átomos de carbono, éster de diglicerina de ácidos alcanocarboxílicos saturados y/o insaturados, ramificados o no ramificados de una longitud de cadena de 8 hasta 24, en particular de 12 hasta 20 átomos de hidrocarburo, éter de monoglicerina de alcoholes saturados y/o insaturados, ramificados o no ramificados de una longitud de cadena de 8 hasta 25 24, en particular de 12 hasta 20 átomos de carbono, éter de diglicerina de alcoholes saturados y/o insaturados, ramificados o no ramificados de una longitud de cadena de 8 hasta 24, en particular de 12 hasta 20 átomos de carbono, éster de polipropilenglicol de ácidos alcanocarboxílicos saturados y/o insaturados, ramificados o no ramificados de una longitud de cadena de 8 hasta 24, en particular de 12 hasta 20 átomos de carbono, éster de poliglicerilo de ácidos alcanocarboxílicos saturados y/o insaturados, ramificados o no 30 ramificados de una longitud de cadena de 8 hasta 24, en particular de 12 hasta 20 átomos de carbono, éster de sorbitán de ácidos alcanocarboxílicos saturados y/o insaturados, ramificados o no ramificados de una longitud de cadena de 8 hasta 24, en particular de 12 hasta 20 átomos de carbono. Preferred Ag / Ac emulsifiers may be used: fatty alcohols with 8 to 30 carbon atoms, sanitized and / or unsaturated, branched or unbranched alkanocarboxylic acid monoglycerin esters of a chain length of 8 to 24, in particular from 12 to 20 carbon atoms, diglycerin ester of saturated and / or unsaturated alkanocarboxylic acids, branched or unbranched chain lengths from 8 to 24, in particular from 12 to 20 hydrocarbon atoms, monoglycerin ether of saturated alcohols and / or unsaturated, branched or unbranched of a chain length from 8 to 25 24, in particular from 12 to 20 carbon atoms, diglycerin ether of saturated and / or unsaturated, branched or unbranched alcohols of a chain length from 8 to 24, in particular from 12 to 20 carbon atoms, polypropylene glycol ester of saturated and / or unsaturated, branched or unbranched alkanocarboxylic acids of a chain length of 8 to 24, in particular 12 to 20 carbon atoms, polyglyceryl ester of saturated and / or unsaturated alkanocarboxylic acids, branched or unbranched 30 of a chain length of 8 to 24, in particular 12 up to 20 carbon atoms, sorbitan ester of saturated and / or unsaturated alkanocarboxylic acids, branched or unbranched with a chain length of 8 to 24, in particular 12 to 20 carbon atoms.
Los emulgentes Ag/Ac preferidos son el diisoestearato de poliglicerilo 3, isoestearato de poliglicerilo 4, dipolihidroxiestearato de poliglicerilo 2, dimeticona de cetilo PEG/PPG-10-1, dipolihidroxiestearato de PEG-35 30, perisoestearato de sorbitán, copoliol cetildimeticona, aceite de castor hidrogenado PEG-7, Copolímero de PEG 45/dodecilglicol, copolímero de PEG 22/dodecilglicol, iso estearato de pentaeritritilo, succinato de isoestearildiglicerilo, isoestearato de sorbitán, sesquiisoestearato de poliglicerilo 2, isoestearato de glicerilo, estearato de sorbitán, aceite de castor hidrogenado PEG-25, peroleato de sorbitán PEG-40, oleato de sorbitán, perisoestearato de sorbitán PEG-40, oleato de poliglicerilo-3, sesquioleato de poliglicerilo-2 y 40 isoestearato de poliglicerilo-4. Preferred Ag / Ac emulsifiers are polyglyceryl 3 diiso stearate, polyglyceryl 4 isostearate, polyglyceryl dipolyhydroxystearate 2, cetyl dimethicone PEG / PPG-10-1, PEG-35 30 dipolyhydroxystearate, sorbitanimethyrateimethyl copolyol, copolyol cetyl ketone hydrochloride PEG-7 hydrogenated beaver, PEG 45 / dodecyl glycol copolymer, PEG 22 / dodecylglycol copolymer, pentaerythrityl iso stearate, isostearyldiglyceryl succinate, sorbitan isostearate, polyglyceryl sesquisoarate 2, sorbitan sorbrate hydratearate stearate, hydroxy stearate hydrochloride PEG-25, sorbitan peroxide PEG-40, sorbitan oleate, sorbitan perisoesterate PEG-40, polyglyceryl-3 oleate, polyglyceryl-2 sesquioleate and 40 polyglyceryl-4 isostearate.
Los emulgentes Ag/Ac especialmente preferidos son el copolímero de polietilenglicol-45/dodecilglicol, el diisoestearato de poliglicerilo-3, el dipolihidroxiestearato PEG-30, isoestearato de sorbitán, estearato de sorbitán, isoestearato de glicerilo, estearato de glicerilo y oleato de sorbitán. Especially preferred Ag / Ac emulsifiers are the polyethylene glycol-45 / dodecylglycol copolymer, the polyglyceryl-3 diisoestearate, the PEG-30 dipolyhydroxystearate, sorbitan isoestearate, sorbitan stearate, glyceryl isostearate, glyceryl oleate stearate.
También es posible renunciar a reducir la energía superficial límite mediante emulgentes o 45 tensoactivos y en lugar de esto estabilizar la superficie límite mediante el almacenamiento de las partículas insolubles en ambas fases. Para ello se pueden emplear polímeros naturales o artificiales (polietileno, nylon, almidón y sus derivados) o bien partículas inorgánicas (TiO2, Al2O3, BaSO4, BN, silicatos, silicatos de alúminio, SiO2, aerosil). It is also possible to give up reducing the surface energy limit by emulsifiers or surfactants and instead stabilize the boundary surface by storing insoluble particles in both phases. Natural or artificial polymers (polyethylene, nylon, starch and its derivatives) or inorganic particles (TiO2, Al2O3, BaSO4, BN, silicates, alumina silicates, SiO2, aerosol) can be used for this.
La fase oleica, los lípidos de las fórmulas conforme a la invención, que se eligen preferiblemente del 50 grupo de aceites polares, por ejemplo, del grupo de lecitinas y de triglicéridos de ácidos grasos, es decir del éster de triglicerina de ácidos alcanocarboxílicos saturados y/o insaturados, ramificados y/o no ramificados son del grupo de los aceites sintéticos, semisintéticos y naturales, como, por ejemplo, glicérido de coco, aceite de oliva, aceite de girasol, aceite de soja, aceite de cacahuete, aceite de colza, aceite de almendras, aceite de The oleic phase, the lipids of the formulas according to the invention, which are preferably chosen from the group of polar oils, for example, from the group of lecithins and triglycerides of fatty acids, that is, from the triglycerin ester of saturated alkanocarboxylic acids and / or unsaturated, branched and / or unbranched are from the group of synthetic, semi-synthetic and natural oils, such as coconut glyceride, olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil , almond oil, oil
palma, aceite de coco, aceite de ricino, aceite de germen de trigo, aceite de semilla de uvas, aceite de cardo, aceite de nuez de macadamia, aceite de onagra y similares. palm, coconut oil, castor oil, wheat germ oil, grape seed oil, thistle oil, macadamia nut oil, evening primrose oil and the like.
Se pueden elegir otros componentes oleicos polares preferidos de la presente invención del grupo de los ésteres de de ácidos alcanocarboxílicos saturados y/o insaturados, ramificados y/o no ramificados de una longitud de cadena de 3 hasta 30 átomos de C y del grupo de los alcoholes saturados y/o insaturados, 5 ramificados y/o no ramificados de longitud de cadena de 3 hasta 30 átomos de C así como del grupo de los ésteres de de ácidos carboxílicos aromáticos y de los alcoholes saturados y/o insaturados, ramificados y/o no ramificados de una longitud de cadena de 3 hasta 30 átomos de C. Dichos esteroles se pueden elegir preferiblemente del grupo del palmitato de octilo, cocoato de octilo, isoestearato de octilo, miristato de octildodecilo, octildodecanol, isononanoato de cetearilo, miristato de isopropilo, palmitato de isopropilo, 10 estearato de isopropilo, oleato de isopropilo, estearato de n-butilo, laurato de n-hexilo, oleato de n-decilo, estearato de isooctilo, estearato de isononilo, nonanoato de isononilo, palmitato de 2-etilhexilo, laurato de 2-etilhexilo, estearato de 2-hexildecilo, palmitato de 2-octildodecilo, heptanoato de estearilo, oleato de oleilo, erucato de oleilo, oleato de erucilo, erucato de erucilo, estearato de tridecilo, trimetilato de tridecilo, así como mezclas sintéticas, semisintéticas y naturales de dichos ésteres, como, por ejemplo, aceite de jojoba. 15 Other preferred polar oleic components of the present invention may be chosen from the group of saturated and / or unsaturated, branched and / or unbranched alkanocarboxylic acid esters of a chain length of 3 to 30 C atoms and from the group of saturated and / or unsaturated alcohols, 5 branched and / or unbranched chain lengths of 3 to 30 C atoms as well as the group of esters of aromatic carboxylic acids and saturated and / or unsaturated alcohols, branched and / or unbranched with a chain length of 3 to 30 C atoms. Said sterols may preferably be selected from the group of octyl palmitate, octyl cocoate, octyl isostearate, octyldodecyl myristate, octyldodecanol, cetearyl isononanoate, isopropyl myristate , isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, stearat or isononyl, isononyl nonanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, 2-octyldodecyl palmitate, stearyl heptanoate, oleyl oleate, oleyl erucate, erucyl erucium belching, tridecyl stearate, tridecyl trimethylate, as well as synthetic, semi-synthetic and natural mixtures of such esters, such as jojoba oil. fifteen
Además la fase oleica se puede elegir del grupo de los éteres y carbonatos de dialquilo, y se prefieren el éter de dicaprililo (Cetiol OE) y/o el carbonato de dicaprililo, por ejemplo, que se conoce como Cetiol CC. In addition, the oleic phase can be chosen from the group of dialkyl ethers and carbonates, and dicaprilyl ether (Cetiol OE) and / or dicaprilyl carbonate are preferred, for example, which is known as Cetiol CC.
Además se prefieren los componentes oleicos del grupo del isoeicosan, diheptanoato neopentilglicol, dicaprilato/dicaprato del propilenglicol, triglicéridos de ácido caprílico/caprínico, diglicerilsuccinato 20 caprílico/cáprico, dicaprilato/dicaprato de butilenglicol, lactato de C12-13-alquilo, ditartrato de C12-13-alquilo, triisoestearina, hexacaprilato/hexacaprato de dipentaeritritilo, monoisoestearato de propilenglicol, tricaprilina, isosorbida de dimetilo. Se prefiere en particular que la fase oleica de las fórmulas conforme a la invención tenga un contenido en C12-15 -benzoato de alquilo o bien su contenido sea total. Also preferred are the oleic components of the isoeicosan group, neopentyl glycol diheptanoate, propylene glycol dicaprilate / dicaprate, caprylic / caprylic acid triglycerides, caprylic / capric diglyceryl succinate, butylene glycol dicaprate dicaprate, C12 lactate, 12 -13-alkyl, triisoestearin, dipentaerythrityl hexacaprilate / hexacaprate, propylene glycol monoisoestearate, tricapriline, dimethyl isosorbide. In particular, it is preferred that the oleic phase of the formulas according to the invention have a C12-15 alkyl benzoate content or its total content.
Los componentes oleicos preferidos son además, por ejemplo, el salicilato de butiloctilo (por ejemplo, 25 que se conoce como Hallbrite BHB), el benzoato de hexadecilo y benzoato de butiloctilo y mezclas de los mismos (Hallstar AB) y/o el naftalato de dietilhexilo Hallbrite TQ o Corapan TQ de H&R). Preferred oleic components are also, for example, butyloctyl salicylate (for example, known as Hallbrite BHB), hexadecyl benzoate and butyloctyl benzoate and mixtures thereof (Hallstar AB) and / or naphthalate diethylhexyl Hallbrite TQ or Corapan TQ from H&R).
También se puede emplear cualquier mezcla de dichos componentes de aceite y cera en el sentido de la presente invención. Any mixture of said oil and wax components can also be used within the meaning of the present invention.
Además la fase oleica puede contener aceites no polares, por ejemplo, aquellos que se eligen del 30 grupo de los hidrocarburos y ceras ramificados y no ramificados, en particular el aceite mineral, la vaselina (Petrolatum), aceite de parafina, escualano y escualeno, poliolefinas, poliisobuteno hidrogenado e isohexadecano. Entre las poliolefinas se conocen los polidecenos de las sustancias preferidas. In addition, the oleic phase may contain non-polar oils, for example, those selected from the group of branched and unbranched hydrocarbons and waxes, in particular mineral oil, petrolatum (Petrolatum), paraffin oil, squalane and squalene, polyolefins, hydrogenated polyisobutene and isohexadecane. Among the polyolefins, polyidecenes of the preferred substances are known.
Preferiblemente la fase oleica puede presentar un contenido en aceites de silicona cíclicos o lineales o constar totalmente de dichos aceites pero en general se prefiere un contenido adicional de otros 35 componentes de fases oleicas además del aceite de silicona o aceites de silicona. Preferably the oleic phase can have a content in cyclic or linear silicone oils or consist entirely of said oils but in general an additional content of 35 other components of oleic phases in addition to the silicone oil or silicone oils is preferred.
Los aceites de silicona son compuestos poliméricos sintéticos de alto peso molecular, en los cuales se unen los átomos de silicio por medio de átomos de oxígeno y las valencias restantes del silicio son saturadas por los radicales de hidrocarburos (principalmente el metilo, etilo, propilo, fenilo, entre otros). Los aceites de silicona se conocen sistemáticamente como poliórganosiloxanos. Los poliórganosiloxanos con un 40 grupo metilo sustituido, que representan la mayoría de compuestos significativos de este grupo y se caracterizan por la fórmula estructural siguiente Silicone oils are synthetic polymeric compounds of high molecular weight, in which silicon atoms are joined by oxygen atoms and the remaining valences of silicon are saturated by hydrocarbon radicals (mainly methyl, ethyl, propyl, phenyl, among others). Silicone oils are systematically known as polyorganosiloxanes. Polyorganosiloxanes with a substituted methyl group, which represent the majority of significant compounds in this group and are characterized by the following structural formula
45 Four. Five
y se conocen como polidimetilsiloxano o Dimeticona (INCI). La dimeticona existe en diferentes longitudes de cadena o con distintos pesos moleculares. 50 and are known as polydimethylsiloxane or dimethicone (INCI). Dimethicone exists in different chain lengths or with different molecular weights. fifty
Los poliórganosiloxanos especialmente preferidos en el sentido de la presente invención son, por Especially preferred polyorganosiloxanes within the meaning of the present invention are, by
ejemplo, los dimetilpolisiloxanos (poli (dimetilsiloxano)), que se conocen bajo el nombre comercial de Abil 10 hasta 10 000 en Th. Goldschmidt. Además se prefieren los polisiloxanos de fenilmetilo (INCI:Fenildimeticona, Feniltrimeticona), las siliconas cíclicas (octametilciclotetrasiloxano o decametilciclopentasiloxano) que según INCI se conocen también como ciclometicona, siliconas aminomodificadas (INCI:Amodimeticona) y ceras de silicona, por ejemplo, copolímeros de polisiloxano-polialquileno (INCI: Dimeticona de estearilo y dimeticona de 5 cetilo) y polisiloxano de dialcoxidimetilo (Estearoxidimeticona y behenoxi estearil dimeticona) que se obtienen en Th. Goldschmidt como tipos de cera Abil diferentes. Pero también se prefiere emplear otros aceites de silicona en el sentido de la presente invención, por ejemplo la cetildimeticona, hexametilciclotrisiloxano, polidimetilsiloxano, poli (metilfenilsiloxano). example, dimethylpolysiloxanes (poly (dimethylsiloxane)), which are known under the trade name of Abil 10 to 10,000 in Th. Goldschmidt. In addition, phenylmethyl polysiloxanes (INCI: Phenyldimethicone, Phenyltrimethicone), cyclic silicones (octamethylcyclotetrasiloxane or decamethylcyclopentasiloxane) which according to INCI are also known as cyclomethicone, aminomodified silicones (INCI: amodimethiclimea, copolymethyl ester, silicone example) are preferred. -polyalkylene (INCI: Stearyl dimethicone and 5-cetyl dimethicone) and dialkoxidimethyl polysiloxane (Stearoxidimethicone and behenoxy stearyl dimethicone) which are obtained in Th. Goldschmidt as different types of Abil wax. But it is also preferred to employ other silicone oils within the meaning of the present invention, for example cetyl dimethicone, hexamethylcyclotrisiloxane, polydimethylsiloxane, poly (methylphenylsiloxane).
Asimismo se prefiere añadir a los preparados en el sentido de la presente invención los antioxidantes 10 convencionales. Conforme a la invención se pueden emplear como antioxidantes favorables todos los antioxidantes convencionales utilizados en aplicaciones cosméticas y/o dermatológicas. It is also preferred to add conventional antioxidants to the preparations within the meaning of the present invention. According to the invention, all conventional antioxidants used in cosmetic and / or dermatological applications can be used as favorable antioxidants.
Se prefieren los antioxidantes procedentes del grupo compuesto por aminoácidos (por ejemplo, glicina, histidina, tirosina, triptófano) y sus derivados, imidazol (por ejemplo, ácido urocanínico) y sus derivados, péptidos como la D,L-Carnosina, D-Carnosina, L-Carnosina y sus derivados (por ejemplo, 15 Anserina), Carotinoides, Carotinas (por ejemplo, alfa-carotina, beta-carotina, licopina) y sus derivados, retinoides como, por ejemplo, Retinol, Retinal y/o ácido retínico y los ésteres correspondientes, ácido alfa-lipónico y sus derivados (por ejemplo, ácido dihidrolipónico), aurotioglucosa, propiltiouracilo y otros tioles (por ejemplo, tioredoxina, glutatión, cisteina, cistina, cistamina y sus ésteres de N-acetilo, metilo, etilo, propilo, amilo, butilo y laurilo, palmitoilo, oleilo, γ-linoleilo, colesterilo y glicerilo) así como sus sales, tiodipropionato de 20 dilaurilo, tiodipropionato de diestearilo, ácido tiodipropiónico y sus derivados (ésteres, éteres, péptidos, lípidos, nucleótidos, nucleósidos y sales) así como compuestos de sulfoximina (por ejemplo, butioninsulfoximina, homocisteinsulfoximina, butioninsulfona, penta-, hexa-, heptationinsulfoximina) en unas dosis tolerables muy bajas (por ejemplo, pmol hasta µmol/kg), además de quelatos metálicos (por ejemplo, α-hidroxiácidos grasos, ácido palmítico, lactoferrina), α-hidroxiácidos (por ejemplo, ácido cítrico, ácido láctico, ácido málico), ácido 25 humínico, ácido biliar, extractos biliares, bilirrubina, biliverdina, EDTA, IDS, EGTA y sus derivados, ácidos grasos insaturados y sus derivados (por ejemplo, ácido γ-linolénico, linólico, oleico), ácido fólico y sus derivados, ácido 2-aminopropiónico, flavonoides, polifenoles, alfa-glucosilrutina, galato de propilo, catequina, ubiquinona y ubiquinol y sus derivados, vitamina C y derivados (por ejemplo, palmitato de ascorbilo, fosfato de ascorbilo de Mg, acetato de ascorbilo), tocoferoles y derivados (por ejemplo, acetato de vitamina E), así como 30 benzoato de coniferilo de la resina de benzol, ácido rutínico y sus derivados, ácido feruláico y sus derivados, butilhidroxitoluol, butilhidroxianisol, resina del ácido nordihidroguayarético, ácido nordihidroguayarético, trihidroxibutirofenona, ácido úrico y sus derivados, manosa y sus derivados, zinc y sus derivados (por ejemplo, ZnO, ZnSO4), selenio y sus derivados (por ejemplo, metionina de selenio), estilbeno y sus derivados (por ejemplo, óxido de estilbeno, óxido de trans-estilbeno) y los derivados adecuados conforme a la invención 35 (sales, ésteres, azúcar, nucleótidos, nucleósidos, péptidos y lípidos) de estas sustancias activas mencionadas. Antioxidants from the group consisting of amino acids (for example, glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazole (for example, urocaninic acid) and their derivatives, peptides such as D, L-Carnosine, D-Carnosine are preferred , L-Carnosine and its derivatives (for example, Anserine), Carotinoids, Carotins (for example, alpha-carotine, beta-carotine, lycopene) and their derivatives, retinoids such as, for example, Retinol, Retinal and / or retinic acid and the corresponding esters, alpha-liponic acid and its derivatives (for example, dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (for example, thioredoxin, glutathione, cysteine, cystine, cystamine and their N-acetyl, methyl, ethyl esters , propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl) as well as their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and its derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximin compounds (for example, butioninsulfoximin, homocysteinsulfoximin, butioninsulfone, penta-, hexa-, heptationinsulfoximin) in very low tolerable doses (for example, pmol to µmol / kg), in addition to metal chelates (for example, fatty α-hydroxy acids, palmitic acid, lactoferrin), α-hydroxy acids (for example, citric acid, lactic acid, malic acid), huminic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, IDS, EGTA and its derivatives, unsaturated fatty acids and their derivatives (eg, γ-linolenic, linoleic, oleic acid), folic acid and its derivatives, 2-aminopropionic acid, flavonoids, polyphenols, alpha-glucosylrutin, propyl gallate, catechin, ubiquinone and ubiquinol and its derivatives, vitamin C and derivatives (for example, ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (for example, ac vitamin E ethate), as well as 30 coniferyl benzoate of benzol resin, rutinic acid and its derivatives, ferulic acid and its derivatives, butylhydroxytoluol, butylhydroxyanisole, nordihydroguayaric acid resin, nordihydroguayaric acid, trihydroxybutyrophenone, uric acid and its derivatives mannose and its derivatives, zinc and its derivatives (for example, ZnO, ZnSO4), selenium and its derivatives (for example, selenium methionine), stilbene and its derivatives (for example, stilbene oxide, trans-stilbene oxide) and Suitable derivatives according to the invention (salts, esters, sugar, nucleotides, nucleosides, peptides and lipids) of these mentioned active substances.
La cantidad de antioxidantes (uno o varios compuestos) en los preparados se sitúa preferiblemente entre el 0,001 y el 30% en peso, en particular entre el 0,05 y el 20% en peso, en particular el 0,1 y el 10% en peso respecto al peso total del preparado. 40 The amount of antioxidants (one or more compounds) in the preparations is preferably between 0.001 and 30% by weight, in particular between 0.05 and 20% by weight, in particular 0.1 and 10% in weight with respect to the total weight of the preparation. 40
Siempre que la vitamina E y/o sus derivados equivalgan al o a los antioxidantes, es preferible que sus concentraciones respectivas se sitúen entre 0,001 y 10% en peso, respecto al peso total de la fórmula. Whenever vitamin E and / or its derivatives are equivalent to the antioxidant (s), it is preferable that their respective concentrations are between 0.001 and 10% by weight, based on the total weight of the formula.
Además al preparado conforme a la invención se le pueden añadir sustancias filtro de rayos UV. Por tanto se prefiere emplear los preparados conforme a la invención como fórmulas fotoprotectoras. In addition to the preparation according to the invention UV filter substances can be added. Therefore it is preferred to use the preparations according to the invention as photoprotective formulas.
Se prefieren las sustancias filtro de rayos UV líquidas a temperatura ambiente en el sentido de la 45 presente invención y estas son el homomentilsalicilato (INCI:homosalato), 2-etilhexil-2-ciano-3,3-difenilacrilato (INCI: Octrocrileno), 2-etilhexil-2-hidroxibenzoato (2-hetilhexilsalicilato , octilsalicilato, INCI: Salicilato de octilo) y ésteres del ácido cinámico, preferiblemente, el ácido 4-metoxicinámico (2-etilhexil-4-metoxicinamato, INCI: metoxicinamato de octilo) e isopentiléster de ácido 4-metoxicinámico (isopentil-4-metoxi-cinamato, INCI:p-metoxicinamato de isoamilo)- 50 The liquid UV filter substances at room temperature within the meaning of the present invention are preferred and these are homomethylsalicylate (INCI: homosalate), 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI: Octrocrylene), 2-ethylhexyl-2-hydroxybenzoate (2-methylhexylsalicylate, octylsalicylate, INCI: octyl salicylate) and cinnamic acid esters, preferably 4-methoxycinnamic acid (2-ethylhexyl-4-methoxycinnamate, INCI: octyl methoxycinnamate) and isopentyl ester of 4-methoxycinnamic acid (isopentyl-4-methoxy-cinnamate, INCI: isoamyl p-methoxycinnamate) - 50
Los pigmentos inorgánicos preferidos son los óxidos metálicos y/o los compuestos metálicos solubles o insolubles en agua, en particular los óxidos de titanio (TiO2), de zinc (ZnO), hierro (Fe2O3), circonio (ZrO2), silicio (SiO2), manganeso (por ejemplo, MnO), aluminio (Al2O3), cerio (por ejemplo, Ce2O3), óxidos mixtos de los metales correspondientes así como mezclas de otros óxidos como el sulfato del bario (BaSO4). Preferred inorganic pigments are metal oxides and / or water soluble or water insoluble metal compounds, in particular titanium oxides (TiO2), zinc (ZnO), iron (Fe2O3), zirconium (ZrO2), silicon (SiO2) , manganese (for example, MnO), aluminum (Al2O3), cerium (for example, Ce2O3), mixed oxides of the corresponding metals as well as mixtures of other oxides such as barium sulfate (BaSO4).
Los pigmentos pueden emplearse en el sentido de la presente invención en forma de dispersiones 55 acuosas o bien oleosas que se obtienen en el comercio. Estas dispersiones previas se añadirán como medios de dispersión y/o de solubilización. The pigments can be used in the sense of the present invention in the form of aqueous or oily dispersions commercially obtained. These prior dispersions will be added as dispersion and / or solubilization media.
Los pigmentos pueden ser tratados superficialmente (“gecoatet” , de manera que por ejemplo se pueda mantener su carácter hidrófilo, anfífilo o hidrófobo. Este tratamiento superficial puede consistir en que el pigmento sea revestido de una capa orgánica y/o inorgánica, delgada, hidrófila y/o hidrófoba. Los diferentes revestimientos superficiales también pueden contener agua en el sentido de la presente invención. The pigments can be treated superficially ("gecoatet", so that for example their hydrophilic, amphiphilic or hydrophobic character can be maintained. This surface treatment may consist of the pigment being coated with a thin, hydrophilic and / or inorganic organic layer. and / or hydrophobic The different surface coatings may also contain water within the meaning of the present invention.
Los revestimientos superficiales inorgánicos en el sentido de la presente invención pueden constar 5 de óxido de aluminio (Al2O3), hidróxido de aluminio Al(OH)3 o bien óxido de aluminio hidratado (también: alúminas, CAS-Nr.:1333-84-2), hexametafosfato sódico (NaPO3)6, metafosfato sódico (NaPO3)n, dióxido de silicio (SiO2) (también sílices, CAS-Nr.:7631-86-9), o bien óxido férrico (Fe2O3). Estos revestimientos superficiales inorgánicos pueden presentarse solos, en combinación, y/o en combinación con materiales de revestimiento orgánicos. 10 Inorganic surface coatings within the meaning of the present invention may consist of 5 aluminum oxide (Al2O3), aluminum hydroxide Al (OH) 3 or hydrated aluminum oxide (also: aluminas, CAS-Nr.:1333-84- 2), sodium hexametaphosphate (NaPO3) 6, sodium metaphosphate (NaPO3) n, silicon dioxide (SiO2) (also silica, CAS-Nr.:7631-86-9), or ferric oxide (Fe2O3). These inorganic surface coatings may be presented alone, in combination, and / or in combination with organic coating materials. 10
Los revestimientos superficiales orgánicos en el sentido de la presente invención pueden constar de estearato de aluminio vegetal o animal, ácido estearínico vegetal o animal, ácido láurico, dimetilpolisiloxano (también:dimeticona), polisiloxano de metilo (meticona), simeticona (una mezcla de dimetilpolisiloxano con una longitud de cadena media de 200 a 350 unidades de dimetilsiloxano y gel de sílice) o ácido algínico. Estos revestimientos superficiales orgánicos pueden presentarse solos, en combinación y/o en combinación 15 con materiales de revestimiento inorgánicos. Organic surface coatings within the meaning of the present invention may consist of vegetable or animal aluminum stearate, vegetable or animal stearinic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methyl polysiloxane (methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 units of dimethylsiloxane and silica gel) or alginic acid. These organic surface coatings may be presented alone, in combination and / or in combination with inorganic coating materials.
Las partículas de óxido de zinc adecuadas conforme a la invención y las dispersiones de las partículas de óxido de zinc se obtienen en las empresas siguientes bajo las denominaciones comerciales correspondientes: Suitable zinc oxide particles according to the invention and dispersions of zinc oxide particles are obtained in the following companies under the corresponding trade names:
- Nombre comercial Tradename
- Revestimiento Coating
- Z-Cote HP1 Z-Cote HP1
- 2% dimeticona 2% dimethicone
- Z-Cote Z-Cote
- / /
- ZnO NDM ZnO NDM
- 5% dimeticona 5% dimethicone
20 twenty
Las partículas de dióxido de titanio adecuadas y las dispersiones previas de partículas de dióxido de titanio se obtienen bajo las siguientes denominaciones comerciales: Suitable titanium dioxide particles and previous dispersions of titanium dioxide particles are obtained under the following trade names:
- Nombre comercial Tradename
- Revestimiento Coating
- MT-100TV MT-100TV
- Hidróxido de aluminio/ácido estearínico Aluminum hydroxide / stearinic acid
- MT-100Z MT-100Z
- Hidróxido de aluminio/ácido estearínico/ Aluminum hydroxide / stearinic acid /
- Eusolex T-2000 Eusolex T-2000
- ALúmina/simeticona Alumina / simethicone
- Dióxido de titanio T805(Uvinul TiO2) Titanium dioxide T805 (Uvinul TiO2)
- Octiltrimetilsilano Octyltrimethylsilane
Las sustancias filtro de rayos UV-A preferibles en el sentido de la presente invención son los derivados de dibenzoilmetano, en particular, el 4-(tert.-butil)-4’-metoxidibenzoilmetano (CAS Nr. 70356-09-1), 25 que es comercializado por Givaudan bajo la marca Parsol® 1789 y bajo el nombre comercial Eusolex®9020. The UV-A filter substances preferable in the sense of the present invention are those derived from dibenzoylmethane, in particular 4- (tert.-butyl) -4'-methoxydibenzoylmethane (CAS No. 70356-09-1), 25 which is marketed by Givaudan under the brand name Parsol® 1789 and under the trade name Eusolex®9020.
Asimismo las sustancias filtro de rayos UV-A adecuadas son las hidroxibenzofenonas. Estas se caracterizan por la fórmula estructural siguiente: Also suitable UV-A filter substances are hydroxybenzophenones. These are characterized by the following structural formula:
30 30
donde where
- - R1 y R2 equivalen a hidrógeno, C1-C20-alquilo, C3-C10-cicloalquilo o bien C3-C10-cicloalquenilo, de forma que los sustituyentes R1 y R2 junto con el átomo de nitrógeno, al que están enlazados, pueden formar un anillo de 5 ó 6 y - R1 and R2 are equivalent to hydrogen, C1-C20-alkyl, C3-C10-cycloalkyl or C3-C10-cycloalkenyl, so that the substituents R1 and R2 together with the nitrogen atom, to which they are linked, can form a 5 or 6 ring and
- - R3 equivale a un radical C1-C20-alquilo - R3 is equivalent to a C1-C20-alkyl radical
Una hidroxibenzofenona especialmente preferida en el sentido de la presente invención es el éster hexílico 5 del ácido 2-(4’-dietilamino-2’-hidroxibenzoilo)-benzoico (también: aminobenzofenona), que se caracteriza por la siguiente estructura: An especially preferred hydroxybenzophenone within the meaning of the present invention is the hexyl ester 5 of 2- (4’-diethylamino-2’-hydroxybenzoyl) -benzoic acid (also: aminobenzophenone), which is characterized by the following structure:
10 10
y se obtiene en Fa. BASF bajo la denominación Uvinul A Plus. 15 and you get in Fa. BASF under the name Uvinul A Plus. fifteen
La cantidad total de una o varias hidroxibenzofenonas en los preparados cosméticos o dermatológicos se elige preferiblemente del intervalo del 0,01 al 20% en peso, preferiblemente del 0,1 al 10% en peso, respecto al peso total de los preparados. The total amount of one or more hydroxybenzophenones in cosmetic or dermatological preparations is preferably selected from the range of 0.01 to 20% by weight, preferably 0.1 to 10% by weight, based on the total weight of the preparations.
Otras sustancias filtro de rayos UV preferidas en el sentido de la presente invención son los filtros de rayos UV solubles en agua, sulfonados, como por ejemplo: 20 Other preferred UV filter substances within the meaning of the present invention are sulphonated water soluble UV filters, such as:
- - El ácido fenilen-1,4-bis-(2-bencimidazil)-3,3’-5,5’-tetrasulfónico y sus sales, en particular las correspondientes sales de sodio, potasio o trietanolamonio, especialmente la sal fenilen-1,4-bis-(2-benzimidazil)-3,3’-5,5’-tetrasulfónico-bis-sódica con la denominación INCI Bisimidazilato CAS-Nº:180898-37-7), que se conoce por ejemplo bajo el nombre comercial Neo Heliopan AP; - Phenylene-1,4-bis- (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and its salts, in particular the corresponding sodium, potassium or triethanolammonium salts, especially the phenylene-1 salt , 4-bis- (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic-bis-sodium with the INCI designation Bisimidazilate CAS-No .: 180898-37-7), which is known for example under the name commercial Neo Heliopan AP;
- - Las sales del ácido 2-fenilbencimidazol-5-sulfónico, como su sal sódica, potásica o de 25 trietanolamonio así como el ácido sulfónico propiamente con la denominación INCI de Fenilbencimidazol sulfónico (CAS-Nº 27503-81-7), que se obtiene por ejemplo bajo el nombre comercial de Eusolex 232 en Merck o bien bajo el nombre de Neo Heliopan Hydro; - The salts of 2-phenylbenzimidazol-5-sulfonic acid, such as its sodium, potassium or triethanolammonium salt as well as the sulfonic acid itself with the INCI designation of Phenylbenzimidazole sulfonic acid (CAS-No. 27503-81-7), which is obtained for example under the trade name of Eusolex 232 in Merck or under the name of Neo Heliopan Hydro;
- - El 1,4-di(2-oxo-10-sulfo-3-bornilidenmetil)-benzol (también: 3,3’-(1,4-fenilendimetilen)-bis-(7,7-dimetil-2-oxo-biciclo-(2.2.1)hept-1-ilmetanosulfó-nico) y sus sales (en particular los 30 correspondientes compuestos 10-sulfato, especialmente la sal de sodio, potasio o trietanolamonio correspondiente), que se conoce también como el ácido benzol-1,4-di(2-oxo-3-bornilidenmetil-10-sulfónico). El ácido benzol-1,4-di(2-oxo-3-bornilidenmetil-10-sulfónico) tiene la denominación INCI de ácido Tereftalidendicanferolsulfónico (CAS-Nº : 90457-82-2) y se obtiene bajo el nombre comercial de Mexoryl SX; 35 - 1,4-di (2-oxo-10-sulfo-3-bornylidenmethyl) -benzol (also: 3,3 '- (1,4-phenylenedimethylene) -bis- (7,7-dimethyl-2-oxo -bicyclo- (2.2.1) hept-1-ylmethanesulfó-nico) and its salts (in particular the corresponding 10-sulfate compounds, especially the corresponding sodium, potassium or triethanolammonium salt), which is also known as benzol acid -1,4-di (2-oxo-3-bornylidenmethyl-10-sulfonic acid) Benzol-1,4-di (2-oxo-3-bornylidenmethyl-10-sulphonic acid) has the INCI designation of Terephthalidendicanferolsulfonic acid ( CAS-Nº: 90457-82-2) and is obtained under the commercial name of Mexoryl SX; 35
- - Derivados del ácido sulfónico del 3-bencilidenalcanfor, como por ejemplo, el ácido 4-(2-oxo-3-bornilidenmetil)-benzolsulfónico, 2-metil-5-(2-oxo-3-bornilidenmetil) sulfónico y sus sales. - Derivatives of 3-benzylidene-camphor sulfonic acid, such as 4- (2-oxo-3-bornylidenmethyl) -benzolsulfonic acid, 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid and its salts.
Sustancias filtro de rayos UV preferidas en el sentido de la presente invención son los llamados filtros de banda ancha, es decir, las sustancias filtro que absorben tanto rayos UV-A como radiación UV-B. Preferred UV filter substances within the meaning of the present invention are the so-called broadband filters, that is, the filter substances that absorb both UV-A and UV-B radiation.
Los filtros de banda ancha preferidos o filtros UV-B son, por ejemplo, los derivados de triazina, 40 como por ejemplo Preferred broadband filters or UV-B filters are, for example, triazine derivatives, such as for example
- 2,4-bis-[4-(2-etilhexiloxi)-2-hidroxi]-fenil}-6-(4-metoxifenil)-1,3,5-triazina (INCI: Aniso Triazina), que se obtiene bajo el nombre comercial de Tinosorb® S ; - 2,4-bis- [4- (2-ethylhexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine (INCI: Aniso Triazine), which is obtained under the trade name of Tinosorb® S;
- Dietilhexilbutilamidotriazona (INCI: dietilhexilbutamidotriazona), que se obtiene bajo el nombre comercial UVASORB HEB; 45 - Diethylhexylbutylamidotriazone (INCI: diethylhexylbutamidotriazone), which is obtained under the trade name UVASORB HEB; Four. Five
- 4,4’,4’’-(1,3,5-triazina-2,4,6-triiltriimino)-tris-benzoico-tris(2-etilhexilester), también : 2,4,6-tris-(anilino-(p-carbo-2’-etil-1’-hexiloxi))-1,3,5-triazina (INCI:octiltriazona), que es comercializado por BASF - 4,4 ', 4' '- (1,3,5-triazine-2,4,6-triyltriimino) -tris-benzoic-tris (2-ethylhexyl ester), also: 2,4,6-tris- ( anilino- (p-carbo-2'-ethyl-1'-hexyloxy)) - 1,3,5-triazine (INCI: octyltriazone), which is marketed by BASF
Aktiengesellschaft bajo el nombre comercial UVINUL® T 150. Aktiengesellschaft under the trade name UVINUL® T 150.
Un filtro de banda ancha preferido en el sentido de la presente invención es también el 2,2’-metilen-bis-(6-(2H-benzotriazol-2-il)-4-(1,1,3,3-tetrametilbutil)-fenol), que se obtiene bajo el nombre comercial de Tinosorb® M. A preferred broadband filter within the meaning of the present invention is also 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl ) -phenol), which is obtained under the trade name of Tinosorb® M.
El filtro de banda ancha preferido en el sentido de la presente invención es además el 2-(2H-5 benzotriazol-2-il)-4-metil-6-[2-metil-3-(1,3,3,3-tetrametil-1-((trimetilsilil) oxi)disiloxanil)propil]-fenol (CAS-Nr.:155633-54-8) con la denominación INCI de drometrizol trisiloxano, que se obtiene bajo la denominación comercial Mexoryl® XL. The preferred broadband filter within the meaning of the present invention is also 2- (2H-5 benzotriazol-2-yl) -4-methyl-6- [2-methyl-3- (1,3,3,3 -tetramethyl-1 - ((trimethylsilyl) oxy) disiloxanyl) propyl] -phenol (CAS-Nr.:155633-54-8) under the INCI designation of drometrizol trisiloxane, which is obtained under the trade name Mexoryl® XL.
Las sustancias filtro de rayos UV siguientes pueden ser solubles en aceite o en agua. Las sustancias filtro solubles en aceite preferidas son, por ejemplo: 10 The following UV filter substances can be soluble in oil or water. Preferred oil soluble filter substances are, for example:
- - Derivados de 3-bencilidenalcanfor, preferiblemente 3-(4-metilbenciliden)alcanfor, 3-bencilidenalcanfor; - Derivatives of 3-benzylidene camphor, preferably 3- (4-methylbenzylidene) camphor, 3-benzylidenecamphor;
- - Derivados del ácido 4-aminobenzoico, preferiblemente éster 2-(etilhexílico) del ácido 4-(dimetilamino) benzoico, éster amílico del ácido 4-dimetil aminobenzoico; - Derivatives of 4-aminobenzoic acid, preferably 2- (ethylhexyl) ester of 4- (dimethylamino) benzoic acid, amyl ester of 4-dimethyl aminobenzoic acid;
- - Derivados de la benzofenona, preferiblemente la 2-hidroxi-4-metoxibenzofenona, 2-15 hidroxi-4-metoxi-4’-metilbenzofenona,2,2’-dihidroxi-4-metoxibenzo-fenona - Benzophenone derivatives, preferably 2-hydroxy-4-methoxybenzophenone, 2-15 hydroxy-4-methoxy-4’-methylbenzophenone, 2,2’-dihydroxy-4-methoxybenzoenophenone
- - Filtros UV unidos al polímero, - UV filters attached to the polymer,
- - el copolímero 3-(4-(2,2-bis-etoxicarbonilvinil)-fenoxi)propenil)-metoxisiloxano/dimetilsiloxano, que se conoce bajo el nombre comercial de Parsol® SLX. - the 3- (4- (2,2-bis-ethoxycarbonylvinyl) -phenoxy) propenyl) -methoxysiloxane / dimethylsiloxane copolymer, which is known under the trade name of Parsol® SLX.
Asimismo se prefiere añadir a los preparados en el sentido de la presente invención, los 20 antioxidantes convencionales. Conforme a la invención se pueden emplear como antioxidantes favorables todos los antioxidantes convencionales para aplicaciones cosméticas y/o dermatológicas. It is also preferred to add to the preparations within the meaning of the present invention, the conventional antioxidants. According to the invention, all conventional antioxidants for cosmetic and / or dermatological applications can be used as favorable antioxidants.
La cantidad de antioxidantes (uno o varios compuestos) en los preparados oscila preferiblemente entre 0,001 y 30% en peso, en particular entre 0,05 y 20% en peso, especialmente entre el 1 y el 10% en peso respecto al peso total del preparado. 25 The amount of antioxidants (one or more compounds) in the preparations preferably ranges from 0.001 to 30% by weight, in particular between 0.05 and 20% by weight, especially between 1 and 10% by weight with respect to the total weight of the prepared. 25
Siempre que el preparado cosmético o dermatológico equivalga a una solución o emulsión o dispersión en el sentido de la presente invención, se pueden emplear como disolventes: Provided that the cosmetic or dermatological preparation is equivalent to a solution or emulsion or dispersion within the meaning of the present invention, it can be used as solvents:
La sustancias filtros solubles en agua preferidas son, por ejemplo: The preferred water soluble filter substances are, for example:
Derivados de ácido sulfónico del 3-bencilidenalcanfor, como el ácido 4-(2-oxo-3-bornilidenmetil)benzolsulfónico, el ácido 2-metil-5-(2-oxo-3-bornilidenmetil)sulfónico y sus sales. 30 Sulfonic acid derivatives of 3-benzylidenecamphor, such as 4- (2-oxo-3-bornylidenmethyl) benzolsulfonic acid, 2-methyl-5- (2-oxo-3-bornylidenmethyl) sulfonic acid and its salts. 30
Otra sustancia filtro fotoprotectora que se emplea preferiblemente conforme a la invención es el etilhexil-2-ciano-3,3-difenilacrilato (octocrilen), que se obtiene bajo la denominación Uvinul® N 539. Another photoprotective filter substance which is preferably used in accordance with the invention is ethylhexyl-2-cyano-3,3-diphenylacrylate (octocrilen), which is obtained under the name Uvinul® N 539.
Los preparados especialmente preferidos en el sentido de la presente invención, que se caracterizan por una elevada protección ante rayos UV-A y UV-B contienen además de las sustancias filtro conforme a la invención otros filtros de banda ancha y/o de rayos UV-A, en particular, los derivados de dibenzoilmetano (por 35 ejemplo, el 4-(tert.-butil)-4’-metoxidibenzoilmetno), fenilen-1,4-bis-(2-benzimidazil)-3,3’-5,5’-tetrasulfónico y/o sus sales, el 1,4-di(2-oxo-10-sulfo-3-bornidilenmetil)-benzol y/o sus sales y/o el 2,4-bis-{[4-(2-etil-hexiloxi)-2-hidroxi]-fenil}-6-(4-metoxifenil)-1,3,5-triazina, respectivamente solo o en cualquier combinación. Especially preferred preparations within the meaning of the present invention, which are characterized by high protection against UV-A and UV-B rays in addition to the filter substances according to the invention other broadband and / or UV-ray filters A, in particular, the dibenzoylmethane derivatives (for example, 4- (tert.-butyl) -4'-methoxydibenzoylmethane), phenylene-1,4-bis- (2-benzimidazyl) -3,3'-5 , 5'-tetrasulfonic acid and / or its salts, 1,4-di (2-oxo-10-sulfo-3-bornidylenmethyl) -benzol and / or its salts and / or 2,4-bis - {[4 - (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine, respectively alone or in any combination.
La lista de los filtros UV mencionados que se pueden empelar en el sentido de la presente invención no debe estar limitada. 40 The list of the mentioned UV filters that can be used in the sense of the present invention should not be limited. 40
Los preparados conforme a la invención contienen preferiblemente las sustancias que absorben la radiación UV en el campo UV-A y/o UV-B, en una cantidad total de, por ejemplo, 0,1% en peso hasta 30% en peso, preferiblemente del 0,5 hasta el 20% en peso, en particular del 1,0 hasta el 15,0% en peso, respecto al peso total de los preparados, para disponer de preparados cosméticos que protejan la piel ante todo el campo de radiación ultravioleta. Pueden servir también como medio protector del cabello. 45 The preparations according to the invention preferably contain the substances that absorb UV radiation in the UV-A and / or UV-B field, in a total amount of, for example, 0.1% by weight to 30% by weight, preferably from 0.5 to 20% by weight, in particular from 1.0 to 15.0% by weight, with respect to the total weight of the preparations, to have cosmetic preparations that protect the skin from the entire field of ultraviolet radiation . They can also serve as a protective means of hair. Four. Five
Los preparados que se presentan como emulsiones contienen especialmente uno o varios hidrocoloides. Estos hidrocoloides se pueden elegir preferiblemente del grupo de las gomas, polisacáridos, derivados de celulosa, sílices y aerosiles, silicatos de capa, poliacrilatos y/o otros polímeros. Preparations presented as emulsions especially contain one or more hydrocolloids. These hydrocolloids can preferably be chosen from the group of gums, polysaccharides, cellulose derivatives, silica and aerosols, layer silicates, polyacrylates and / or other polymers.
Entre las gomas se encuentra la savia, que se endurece con el aire y forma resinas o los extractos de las plantas acuáticas. De este grupo en el sentido de la presente invención se pueden elegir por ejemplo la goma arábiga, harina o polvo de algarroba, tragacanto, karaya, goma de guar, pectina, goma Gelan, carragenina, agar, algina, chondrus, goma de xantano. Among the gums is the sap, which hardens with air and forms resins or extracts from aquatic plants. From this group within the meaning of the present invention, for example, gum arabic, locust bean flour or tragacanth, karaya, guar gum, pectin, Gelan gum, carrageenan, agar, algina, chondrus, xanthan gum can be chosen.
Es preferible el uso de gomas derivatizadas, como por ejemplo, la hidroxipropil guar (Jaguar® HP 8). 5 The use of derivatized gums, such as hydroxypropyl guar (Jaguar® HP 8), is preferable. 5
Entre los polisacáridos y derivados se encuentran, por ejemplo, el ácido hialurónico, la quitina y el quitosano, el sulfato de chondroitina, el almidón y los derivados de almidón. Among the polysaccharides and derivatives are, for example, hyaluronic acid, chitin and chitosan, chondroitin sulfate, starch and starch derivatives.
Entre los derivados de celulosa se encuentran, por ejemplo, metilcelulosa, carboximetilcelulosa, hidroxietilcelulosa, hidroxipropilmetilcelulosa. Cellulose derivatives include, for example, methyl cellulose, carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose.
Entre los silicatos de capa se encuentran las arcillas sintéticas y de origen natural cómo, por ejemplo, 10 Montmorillonita, Bentonita, Hectorita, Laponita, silicato de magnesio aluminio como Veegum®. Estas pueden emplearse como tales o en forma modificada como, por ejemplo, la hectorita de estearalconio. Among the layer silicates are synthetic and naturally occurring clays such as, for example, Montmorillonite, Bentonite, Hectorite, Laponite, magnesium aluminum silicate such as Veegum®. These can be used as such or in a modified form such as, for example, stearalkonium hectorite.
También se pueden emplear los geles de ácido silícico, para cuya fabricación se pueden emplear, por ejemplo, ácido silícico pirógeno (por ejemplo los tipos Aerosil 200, 300, 800, R 812 o R 972). The silicic acid gels can also be used, for which manufacture, for example, pyrogenic silicic acid (for example, Aerosil 200, 300, 800, R 812 or R 972 types) can be used.
Se prefieren además Tauratos, por ejemplo, el copolímero de taurato de acriloildimetilo de amonio /VP 15 In addition, Taurates are preferred, for example, the ammonium acryloxy dimethyl taurate / VP 15 copolymer
Entre los poliacrilatos se encuentran, por ejemplo, los tipos Carbopol (Carbopol 980, 981, 1382, 5984, 2984, EDT 2001, ETD 2020, ETD 2050, Ultrez-10 o Pemulen TR1&TR2). Among the polyacrylates are, for example, the Carbopol types (Carbopol 980, 981, 1382, 5984, 2984, EDT 2001, ETD 2020, ETD 2050, Ultrez-10 or Pemulen TR1 & TR2).
Entre los polímeros se encuentran las poliacrilamidas (Seppigel 305), los alcoholes de polivinilo, PVP, copolímero PVP/VA, poliglicoles. Among the polymers are polyacrylamides (Seppigel 305), polyvinyl alcohols, PVP, PVP / VA copolymer, polyglycols.
La fase acuosa de los preparados conforme a la presente invención puede contener las sustancias 20 auxiliares cosméticas convencionales preferidas como, por ejemplo, alcoholes, en particular los de número bajo de carbonos, preferiblemente el etanol y/o isopropanol, los dioles o polioles de número bajo de carbonos así como sus éteres, preferiblemente el propilenglicol, la glicerina, butilenglicol, etilenglicol, éter etilenglicolmonoetílico o monobutílico, éter propilenglicolmonometílico, monoetílico o monobutílico, éter dietilenglicolmonometílico o monoetílico, etilhexilglicerina, metilpropanodiol y productos análogos, polímeros, 25 estabilizadores de espuma, electrolitos cómo, por ejemplo, cloruro sódico o sulfato de magnesio así como en particular uno o varios espesantes, que se pueden elegir preferiblemente del grupo del dióxido de silicio, silicato de aluminio, polisacáridos o sus derivados, por ejemplo, ácido hialurónico, goma de xantano, hidroxipropilmetilcelulosa, en particular los del grupo de los poliacrilatos, preferiblemente un poliacrilato del grupo de los llamados carbopolos, por ejemplo carbopolos de los tipos 980, 981, 984, 1342, 1382, 2984 y 30 5984, asimismo los tipos ETD 2001, 2020, 2050 y Carbopol Ultrez 10, solos o en combinación. The aqueous phase of the preparations according to the present invention may contain preferred conventional cosmetic auxiliary substances such as, for example, alcohols, in particular those of low carbon numbers, preferably ethanol and / or isopropanol, diols or number polyols low carbons and their ethers, preferably propylene glycol, glycerin, butylene glycol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether, ethylhexyglycerol polymers, stabilizer, polyether polymers electrolytes such as, for example, sodium chloride or magnesium sulfate as well as in particular one or more thickeners, which may preferably be selected from the group of silicon dioxide, aluminum silicate, polysaccharides or their derivatives, for example, hyaluronic acid, gum xanthan, hydroxypropylmethyl cellulose, in particular those of the polyacrylate group, preferably a polyacrylate of the so-called carbopoly group, for example carbophores of types 980, 981, 984, 1342, 1382, 2984 and 30 5984, also types ETD 2001, 2020, 2050 and Carbopol Ultrez 10, alone or in combination.
Los preparados conforme a la invención pueden contener preferiblemente sustancias de autobronceado, como por ejemplo, dihidroxiacetona y/o derivados de melanina en concentraciones del 0,1 hasta el 10% en peso respecto al peso total del preparado. The preparations according to the invention may preferably contain self-tanning substances, such as dihydroxyacetone and / or melanin derivatives in concentrations of 0.1 to 10% by weight with respect to the total weight of the preparation.
Además los preparados pueden contener preferiblemente conforme a la invención repelentes para 35 proteger de moscas, garrapatas y arañas y similares. Se prefieren, por ejemplo, el N,N-dietil-3-metilbenzamida (nombre comercial: Metadelphen, “DEET”), el ftalato de dimetilo (nombre comercial:Palatinol M, DMP) así como el éster etílico del ácido 3-(-n-butil-N-acetil-amino)-propiónico (bajo el nombre comercial de Insekt Repellent® 3535). Los repelentes se pueden emplear solos o en combinación. También se pueden emplear aceites aromáticos o similares. 40 Furthermore, the preparations may preferably contain, according to the invention, repellents to protect against flies, ticks and spiders and the like. Preferred are, for example, N, N-diethyl-3-methylbenzamide (trade name: Metadelphen, "DEET"), dimethyl phthalate (trade name: Palatinol M, DMP) as well as the 3- (ethyl ester of acid ( -n-butyl-N-acetyl-amino) -propionic (under the trade name of Insekt Repellent® 3535). Repellents can be used alone or in combination. Aromatic oils or the like can also be used. 40
Como medios humectantes y/o sustancias que humedecen la piel se conocen las sustancias o mezclas de sustancias que aportan a los preparados cosméticos o dermatológicos la propiedad de reducir la liberación de humedad de la capa córnea (también llamada transepidermal water loss (TEWL) y/o influir positivamente en la hidratación de la capa de la córnea, tras su aplicación o distribución por la superficie de la piel. Los humectantes preferidos en el sentido de la presente invención son, por ejemplo, glicerina, ácido 45 láctico y/o lactatos, en particular el lactato sódico, butilenglicol, propilenglicol, pantenol, fucogel, soja de glicina, etilhexilglicerina, ácido pirrolidoncarboxílico y sus derivados así como la urea. Además se prefieren los humectantes poliméricos del grupo de los polisacáridos solubles en agua y/o hinchables en agua y/o gelificables con ayuda de agua. En particular se prefieren, por ejemplo, el ácido hialurónico, quitosano y/o un polisacárido rico en fucosa, que se encuentra en el Chemical Abstracts bajo el número de registro 178463-23-50 5 y, por ejemplo, se obtienen bajo la denominación Fucogel® 1000. Los humectantes pueden ser empleados preferiblemente como principios activos antiarrugas para la profilaxis y el tratamiento de trastornos cutáneos cosméticos o dermatológicos, como por ejemplo, los que aparecen al envejecer la piel. As moisturizing media and / or substances that moisturize the skin are known substances or mixtures of substances that give cosmetic or dermatological preparations the property of reducing moisture release from the corneal layer (also called transepidermal water loss (TEWL) and / or positively influence the hydration of the cornea layer, after application or distribution on the surface of the skin.The preferred humectants within the meaning of the present invention are, for example, glycerin, lactic acid and / or lactates, in particular, sodium lactate, butylene glycol, propylene glycol, panthenol, fucogel, glycine soy, ethylhexylglycerin, pyrrolidoncarboxylic acid and its derivatives, as well as urea, and polymeric humectants of the water-soluble and / or water-swellable polysaccharides group are also preferred. and / or gellable with the aid of water, in particular, for example, hyaluronic acid, chitosan and / or a polysaccharide ri co in fucose, which is found in the Chemical Abstracts under registration number 178463-23-50 5 and, for example, are obtained under the name Fucogel® 1000. The humectants can preferably be used as anti-wrinkle active ingredients for prophylaxis and the treatment of cosmetic or dermatological skin disorders, such as those that appear as the skin ages.
Los preparados cosméticos o dermatológicos conforme a la invención pueden contener además preferiblemente, si bien no obligatoriamente, materiales de relleno, que mejoren las propiedades sensoriales y cosméticas de las fórmulas y proporcionen, por ejemplo, una sensación sedosa y aterciopelada The cosmetic or dermatological preparations according to the invention may also preferably contain, although not necessarily, fillers, which improve the sensory and cosmetic properties of the formulas and provide, for example, a silky and velvety feel.
o bien refuercen esa sensación en la piel. Los materiales de relleno preferidos en el sentido de la presente invención son almidón, derivados de almidón (por ejemplo, almidón de tapioca, fosfato de almidón, succinato 5 de octenilo de almidón de aluminio o sodio y similares), pigmentos, que o bien tienen un efecto colorante o actúan como filtro UV (como, por ejemplo, el nitruro de boro etc...) y/o los Aerosiles® (CAS-Nr.7631-86-9). or reinforce that feeling on the skin. Preferred fillers in the sense of the present invention are starch, starch derivatives (for example, tapioca starch, starch phosphate, aluminum or sodium starch octenyl succinate 5 and the like), pigments, which either have a coloring effect or act as a UV filter (such as boron nitride etc ...) and / or Aerosiles® (CAS-Nr. 7631-86-9).
Para su aplicación se aplican y se frotan sobre la piel y/o el cabello los preparados en forma de bola siguiendo el método habitual en cosmética. For its application, ball-shaped preparations are applied and rubbed on the skin and / or hair following the usual method of cosmetics.
Los preparados cosméticos y dermatológicos conforme a la invención pueden estar compuestos de 10 preparados cosméticos y/o dermatológicos usuales además de los componentes conforme a la invención, y servir para la fotoprotección cosmética y/o dermatológica, para modificar o influir en determinados estados de la piel, además de para el tratamiento, el cuidado de la piel y/o del cabello y como producto de maquillaje en la cosmética decorativa. The cosmetic and dermatological preparations according to the invention may be composed of 10 usual cosmetic and / or dermatological preparations in addition to the components according to the invention, and serve for cosmetic and / or dermatological photoprotection, to modify or influence certain states of the skin, in addition to treatment, skin and / or hair care and as a makeup product in decorative cosmetics.
Conforme a las composiciones cosméticas y/o dermatológicas tópicas en el sentido de la presente 15 invención y según su estructura, se emplearán por ejemplo como productos para el cuidado de la piel, productos protectores cutáneos, productos para proteger del sol, tratamientos para el cabello, cuidados de día y de noche, cuidado de determinadas zonas de la piel como manos, cara, pies, etc... According to the topical cosmetic and / or dermatological compositions within the meaning of the present invention and according to their structure, they will be used, for example, as skin care products, skin protective products, sun protection products, hair treatments , day and night care, care of certain areas of the skin such as hands, face, feet, etc ...
El empleo de los preparados cosméticos en forma de bola conforme a la invención se aplica también a la profilaxis y el tratamiento de síntomas de envejecimiento de la piel, para evitar y reducir la formación y el 20 desarrollo de arrugas y pliegues así como para el tratamiento y cuidado de la piel envejecida. Así se puede aplicar preferiblemente una única bola que contiene ubiquinona, ubiquinol, retinol y derivados, dehidroepiandrosterona (DHEA), isoflavonoides (insbes, gesinsteína, daidzeina), creatina, fitoestrógenos, estrógenos, ostradiol y derivados, niacinamida, polifenoles (alfa-glucosilrutina) o bien otras sustancias eficaces contra las arrugas. 25 The use of cosmetic preparations in the form of a ball according to the invention also applies to the prophylaxis and treatment of skin aging symptoms, to avoid and reduce the formation and development of wrinkles and folds as well as for the treatment and aged skin care. Thus, a single ball containing ubiquinone, ubiquinol, retinol and derivatives, dehydroepiandrosterone (DHEA), isoflavonoids (insbes, gesinstein, daidzein), creatine, phytoestrogens, estrogens, ostradiol and derivatives, niacinamide, polyphenols (alpha-glucosyl) or other substances effective against wrinkles. 25
Además se prefiere el empleo de los preparados cosméticos en forma de bola conforme a la invención para la profilaxis y el tratamiento de síntomas de piel seca. Los principios activos adecuados para esta finalidad son: aceites naturales (aceite de soja, aceite de onagra, aceite de jojoba, aceite de macadamia, aceite de ricino), ceramidas, en particular, Ceramida I, III y VI, colesterol, fitoesteroles, ácidos grasos con una longitud de cadena de C 16-26, en particular el ácido linoleico, carnitina y sus derivados, urea, polioles como 30 la glicerina, butilenglicol, propilenglicol y dihidropropilenglicol, pseudoceramidas; electrolitos como el cloruro sódico y taurina, alcoholes grasos así como ceras. In addition, the use of cosmetic preparations in the form of a ball according to the invention is preferred for the prophylaxis and treatment of dry skin symptoms. The active ingredients suitable for this purpose are: natural oils (soybean oil, evening primrose oil, jojoba oil, macadamia oil, castor oil), ceramides, in particular, Ceramide I, III and VI, cholesterol, phytosterols, acids fatty acids with a chain length of C 16-26, in particular linoleic acid, carnitine and its derivatives, urea, polyols such as glycerin, butylene glycol, propylene glycol and dihydropropylene glycol, pseudoceramides; electrolytes such as sodium chloride and taurine, fatty alcohols as well as waxes.
Además es preferible el uso de los preparados cosméticos en forma de bola conforme a la invención para la profilaxis y el tratamiento de síntomas de piel sensible o inflamada. Los principios activos preferidos para esta finalidad son: Sustancias del cardo mariano, en particular la silimarina, extracto de hamamelina, 35 extracto de manzanilla, sustancias del interior de la planta del palo dulce (ácido de glicerricino, ácido acetilsalicílico, diclofenac, triterpeno pentacíclico (Sericosidos, ácido urcólico), licochalconas y pantenol. In addition, the use of cosmetic preparations in the form of a ball according to the invention is preferable for the prophylaxis and treatment of symptoms of sensitive or inflamed skin. Preferred active ingredients for this purpose are: Milk thistle substances, in particular silymarin, witch hazel extract, chamomile extract, substances inside the sweet stick plant (glycerrhino acid, acetylsalicylic acid, diclofenac, pentacyclic triterpene ( Sericosides, urcolic acid), licochalconas and panthenol.
Además es preferible el empleo de preparados cosméticos en forma de bola conforme a la invención para la profilaxis y el tratamiento de síntomas de piel poco pigmentada. Los principios activos preferidos con esta finalidad son: inhibidores de tirosina, derivados de hidroquinona, ácido dioico, ácido lipónico y sus 40 derivados así como el ácido kójico. In addition, it is preferable to use cosmetic preparations in the form of a ball according to the invention for the prophylaxis and treatment of symptoms of poorly pigmented skin. Preferred active ingredients for this purpose are: tyrosine inhibitors, hydroquinone derivatives, dioic acid, liponic acid and its derivatives as well as kojic acid.
También es posible y una ventaja emplear los compuestos conforme a la invención como base de fórmulas farmacéuticas. Se prefiere el empleo de preparados cosméticos en forma de bola conforme a la invención para la profilaxis y el tratamiento de síntomas de piel enferma. Estados relevantes pero no exclusivamente enfermizos de la piel son la psoriasis, el acné, la neurodermitis y otras enfermedades atópicas 45 como la dermatitis atópica, el cáncer de piel o melanoma, herpes, la micosis, ictiosis, pitiriasis, seborreas, pelagra, eccemas de contacto y alergias. Los principios activos adecuados para dichos fines de aplicación son los antibióticos como el ácido fusidínico, la eritromicina, sulfadiazina, clindamicina, tetraciclina, tirotricina aminoglucósido, bacitracina, cloroanfenicol, virustáticos (por ejemplo, aciclovir, idoxuridina, penciclovir), antimicóticos (por ejemplo, niastatina, anfotericina, clotrimazol, econazol, cetoconazol, naftifina, terbinafina), 50 aletrina, citostáticos (5-fluoruracilo), antiflogísticos (hidrocortisona, betametasona; prednisolona, triamcinoloacetónico, dexametasona, diclofenac, bufexamac), inmunosupresores (ciclosporina A, beta-interferona), antipsoriáticos (ditranol, psoraleno, tazaroteno), medios para el acné (ácido retínico, isotretinoina, peróxido de benzoilo, adapaleno); capsaicina, ácido azelaina, queratolíticos (ácido salicílico, ácido láctico), antihistamínicos (azelastina, levocabastina, cromoglicina disódica); antipsoriáticos (ditranol, calcitrol, 55 psoraleno) y vitaminas (en particular, las vitaminas A, B y C). It is also possible and an advantage to use the compounds according to the invention as the basis of pharmaceutical formulas. The use of cosmetic preparations in the form of a ball according to the invention is preferred for the prophylaxis and treatment of symptoms of diseased skin. Relevant but not exclusively diseased skin conditions are psoriasis, acne, neurodermatitis and other atopic diseases 45 such as atopic dermatitis, skin cancer or melanoma, herpes, mycosis, ichthyosis, pityriasis, seborrhoea, pellagra, eczema of contact and allergies The active ingredients suitable for such application purposes are antibiotics such as fusidinic acid, erythromycin, sulfadiazine, clindamycin, tetracycline, thyrotricine aminoglycoside, bacitracin, chlorophenyl, virustatic (for example, acyclovir, idoxuridine, penciclovir), for example, antifungal niastatina, amphotericin, clotrimazole, econazole, ketoconazole, naftifine, terbinafine), 50 allethrin, cytostatics (5-fluorouracil), antiphlogistics (hydrocortisone, betamethasone, prednisolone, triamcinoloacetónico, dexamethasone, diclofenac, bufexamac), immunosuppressants (cyclosporin A, beta-interferon ), antipsoriatics (ditranol, psoralen, tazarotene), means for acne (retinic acid, isotretinoin, benzoyl peroxide, adapalene); capsaicin, azelaine acid, keratolytics (salicylic acid, lactic acid), antihistamines (azelastine, levocabastine, disodium chromoglycine); antipsoriatics (ditranol, calcitrol, 55 psoralen) and vitamins (in particular, vitamins A, B and C).
Una aplicación posible y especialmente preferida consiste en ofrecer en un envase las bolas con distintos fines de aplicación, por ejemplo, para el cuidado de día y de noche, bolas con distintos colores, sabores, distintos factores de intensidad en la fotoprotección o distintos principios activos. En dicha aplicación es preferible diferenciar las bolas de distinta composición mediante formas diferentes. A possible and especially preferred application is to offer in a container the balls with different application purposes, for example, for day and night care, balls with different colors, flavors, different photoprotection intensity factors or different active principles . In said application it is preferable to differentiate the balls of different composition by different shapes.
No por último hablaremos del empleo de preparados cosméticos en forma de bola conforme a la 5 invención para la profilaxis y el tratamiento de la piel impura así como de la celulitis. Finally, we will not talk about the use of cosmetic preparations in the form of a ball according to the invention for the prophylaxis and treatment of impure skin as well as cellulite.
La fabricación de preparados en forma de bola conforme a la invención se ha descrito a modo de ejemplos y consiste inicialmente en la fabricación de una emulsión Ag/Ac a partir de los componentes esenciales de la invención con un método determinado según la aplicación. The manufacture of ball-shaped preparations according to the invention has been described by way of examples and initially consists in the manufacture of an Ag / Ac emulsion from the essential components of the invention with a method determined according to the application.
La fabricación de emulsiones a base de fases lipídicas y acuosas mezcladas es bien conocida y 10 normalmente se realiza aplicando energía mecánica y utilizando los medios de agitación apropiados y homogenizadores. Puesto que las emulsiones conforme a la invención son sólidas a temperatura ambiente, todas las etapas de trabajo (adición y mezcla de sustancias, homogenización, desespumación eventual introduciendo vacío) deben llevarse a cabo a temperaturas superiores a la del punto de fusión de la fase lipídica. En general esto no tiene importancia si se añade inicialmente la fase lipídica o bien primero la fase 15 acuosa. Si se utilizan instalaciones no optimizadas es preferible que para la fabricación de una emulsión Ag/Ac se coloque primero la fase lipídica. The manufacture of emulsions based on mixed lipid and aqueous phases is well known and is usually carried out by applying mechanical energy and using the appropriate stirring means and homogenizers. Since the emulsions according to the invention are solid at room temperature, all working stages (addition and mixing of substances, homogenization, eventual defoaming by introducing vacuum) must be carried out at temperatures higher than the melting point of the lipid phase. . In general this does not matter if the lipid phase is added initially or the aqueous phase first. If non-optimized installations are used, it is preferable that the lipid phase is placed first for the manufacture of an Ag / Ac emulsion.
Así la fórmula descrita como ejemplo 1 puede fabricarse del modo siguiente: Ceresina, palmitato de metilo, polietileno, copolímero de PEG-45/dodecilglicol, diisoestearato de poligliceril-3, dimeticona, fenoxietanol y diisetionato de hexamidina se funden agitando y se calientan a 70ºC (fase lipídica). 20 Thus the formula described as example 1 can be manufactured as follows: Ceresin, methyl palmitate, polyethylene, copolymer of PEG-45 / dodecylglycol, polyglyceryl-3 diisoestearate, dimethicone, phenoxyethanol and hexamidine diisethionate are melted and heated to 70 ° C (lipid phase). twenty
Na-EDTA, alfa-glucosilrutina, glicerina, palmitato de ascorbilo, colorante y ácido cítrico se disuelven en agua y se calienta la solución a 70ºC (fase acuosa). Na-EDTA, alpha-glucosylrutin, glycerin, ascorbyl palmitate, dye and citric acid are dissolved in water and the solution is heated to 70 ° C (aqueous phase).
La fase acuosa se añade entonces agitando a la fase lipídica de manera que se forma una emulsión Ag/Ac. Esta sse enfría agitando de nuevo y da lugar al perfume a aproximadamente 50ºC. A aproximadamente 45ºC se ajusta la agitación y la emulsión se deja enfriar hasta que finalmente se solidifica. 25 Este es el caso en las circunstancias de una larga espera a temperatura ambiente ya que las emulsiones conforme a la invención muestran tendencias a formar una masa fundida subenfriada. The aqueous phase is then added by stirring to the lipid phase so that an Ag / Ac emulsion is formed. This sse is cooled by stirring again and gives rise to the perfume at approximately 50 ° C. The stirring is adjusted to approximately 45 ° C and the emulsion is allowed to cool until it finally solidifies. This is the case in the circumstances of a long wait at room temperature since the emulsions according to the invention show tendencies to form a subcooled melt.
La fabricación de los restantes ejemplos se realiza del modo correspondiente. The remaining examples are manufactured in the corresponding way.
Para el almacenamiento y/o el transporte se puede solidificar la emulsión así fabricada y después fundirla de nuevo. Para el moldeado de las bolas conforme a la invención la emulsión se funde por encima de su punto 30 de fusión en los moldes o formas correspondientes y se solidifica allí, o bien se comprime en los moldes a presión por debajo de su temperatura de fusión. For storage and / or transport, the emulsion thus manufactured can be solidified and then melted again. For the molding of the balls according to the invention, the emulsion melts above its melting point 30 in the corresponding molds or forms and solidifies there, or it is compressed in the pressure molds below its melting temperature.
El preparado conforme a la invención presenta unas propiedades sensoriales muy mejoradas que no se podrían esperar de los preparados actuales que contienen cera. Se consigue una mejor distribución, capacidad de extracción, consistencia, deslizamiento por la piel y menor adherencia. Respecto a los métodos 35 adecuados par determinar estos parámetros se acude a los conocimientos del experto. The preparation according to the invention has very improved sensory properties that could not be expected from current preparations containing wax. A better distribution, extraction capacity, consistency, sliding through the skin and less adhesion are achieved. With regard to the appropriate methods for determining these parameters, the knowledge of the expert is sought.
Los parámetros como por ejemplo el diámetro de las bolas se entenderán como el diámetro en la dirección de la extensión longitudinal de la bola. Parameters such as the diameter of the balls will be understood as the diameter in the direction of the longitudinal extent of the ball.
Los ejemplos siguientes aclaran los preparados conforme a la invención. Los porcentajes se refieren por tanto, mientras no se indique lo contrario, a la masa total de los preparados. 40 The following examples clarify the preparations according to the invention. The percentages therefore refer, as long as the opposite is not indicated, to the total mass of the preparations. 40
Ejemplo 1 Example 1
- Ceresina Ceresina
- 6% 6%
- Palmitato de metilo Methyl palmitate
- 21% twenty-one%
- Polietileno Polyethylene
- 3% 3%
- Copolímero PEG-45/dodecilglicol PEG-45 / Dodecyl Glycol Copolymer
- 2,5% 2.5%
- Diisoestearato de poliglicerilo-3 Polyglyceryl-3 Diisoesterate
- 1,5% 1.5%
- Simeticona Simethicone
- 0,5 0.5
- Fenoxietanol Phenoxyethanol
- 0,5% 0.5%
- Diisetionato de hexamidina Hexamidine diisethionate
- 0,08% 0.08%
- EDTA, sal sódica EDTA, sodium salt
- 0,2% 0.2%
- alfa-glucosilrutina alpha-glucosylroutine
- 0,2% 0.2%
- glicerina glycerin
- 5% 5%
- Palmitato de ascorbilo Ascorbyl palmitate
- 0,1 0.1
- Colorante Colorant
- c.s. c.s.
- ácido cítrico citric acid
- c.s. c.s.
- Perfume Fragrance
- c.s. c.s.
- agua Water
- hasta 100 up to 100
Ejemplo 2 Example 2
- Ozokerita Ozokerite
- 3% 3%
- Manteca de Karité Shea butter
- 21% twenty-one%
- Polietileno Polyethylene
- 3% 3%
- Copolímero PEG-45/dodecilglicol PEG-45 / Dodecyl Glycol Copolymer
- 1% one%
- Diisoestearato de poliglicerilo-3 Polyglyceryl-3 Diisoesterate
- 1% one%
- Bis-etilhexiloxifenol metoxifenil triazina Bis-ethylhexyloxyphenol methoxyphenyl triazine
- 2% 2%
- Octilmetoxicinamato Octylmethoxycinnamate
- 5% 5%
- Simeticona Simethicone
- 0,5 0.5
- Fenoxietanol Phenoxyethanol
- 0,5% 0.5%
- Parabeno Paraben
- 0,08% 0.08%
- Urea Urea
- 3% 3%
- Glicerina Glycerin
- 6% 6%
- Ácido láctico Lactic acid
- c.s. c.s.
- Colorante Colorant
- c.s. c.s.
- Perfume Fragrance
- c.s. c.s.
- agua Water
- hasta 100 up to 100
Ejemplo 3 Example 3
- Glicérido de coco hidratado Hydrated Coconut Glyceride
- 10% 10%
- Triglicéridos de caprililo/caprinilo Capryl / caprinyl triglycerides
- 25% 25%
- Polietileno Polyethylene
- 3% 3%
- Eucerit Eucerit
- 3,0% 3.0%
- TiO2 TiO2
- 2% 2%
- Aerosil R 812 Aerosil R 812
- 1% one%
- Dekaben LMB Dekaben LMB
- 0,5% 0.5%
- Fenoxietanol Phenoxyethanol
- 0,3% 0.3%
- Ubiquinona Ubiquinone
- 0,1% 0.1%
- Butilenglicol Butylene glycol
- 3,0% 3.0%
- Glicerina Glycerin
- 4% 4%
- Pantenol Panthenol
- 3,0% 3.0%
- Ácido cítrico Citric acid
- c.s. c.s.
- NaOH NaOH
- c.s. c.s.
- Perfume Fragrance
- c.s. c.s.
- agua Water
- hasta 100 up to 100
Ejemplo 4 Example 4
- Miristato de miristilo Myristyl myristate
- 15% fifteen%
- Ricinoleato de cetilo Cetyl Ricinoleate
- 20% twenty%
- Ceresina Ceresina
- 5% 5%
- Diisoestearato de poliglicerilo-3 Polyglyceryl-3 Diisoesterate
- 1,5% 1.5%
- Dipolihidroxiestearato de poliglicerilo-2 Polyglyceryl Dipolyhydroxystearate-2
- 1,5% 1.5%
- Mica Mica
- 2% 2%
- DMDM Hidantoina DMDM hydantoin
- 0,2% 0.2%
- Fenoxietanol Phenoxyethanol
- 0,4% 0.4%
- Creatina Creatine
- 0,3% 0.3%
- Creatinina Creatinine
- 0,1% 0.1%
- Niacinamida Niacinamide
- 0,2% 0.2%
- Glicerina Glycerin
- 5% 5%
- Perfume Fragrance
- c.s. c.s.
- agua Water
- hasta 100 up to 100
Ejemplo 5 Example 5
- Parafina líquida Liquid paraffin
- 15% fifteen%
- Grasa vegetal hidratada Hydrated vegetable fat
- 15% fifteen%
- Cera microcristalina Microcrystalline wax
- 10% 10%
- Eucerit Eucerit
- 1% one%
- Dipolihidroxiestearato de poliglicerilo-2 Polyglyceryl Dipolyhydroxystearate-2
- 1,5% 1.5%
- Nylon Nylon
- 2% 2%
- Estearato de magnesio Magnesium stearate
- 0,5% 0.5%
- Etilhexiloxiglicerina Ethylhexyloxyglycerin
- 0,5% 0.5%
- Fenoxietanol Phenoxyethanol
- 0,5% 0.5%
- Parabeno Paraben
- 0,6% 0.6%
- Palmitato de retinilo Retinyl palmitate
- 0,2% 0.2%
- Pantenol Panthenol
- 1% one%
- Glicerina Glycerin
- 5% 5%
- Perfume Fragrance
- c.s. c.s.
- agua Water
- hasta 100 up to 100
Ejemplo 6 Example 6
- Parafina líquida Liquid paraffin
- 15% fifteen%
- Grasa vegetal hidratada Hydrated vegetable fat
- 15% fifteen%
- Cera microcristalina Microcrystalline wax
- 10% 10%
- Diisoestearato de poliglicerilo-3 Polyglyceryl-3 Diisoesterate
- 1% one%
- Copolímero de PEG-45/dodecilglicol PEG-45 / Dodecyl Glycol Copolymer
- 2% 2%
- Succinato de octenilo de almidón Starch octenyl succinate
- 1% one%
- Estearato de magnesio Magnesium stearate
- 0,5% 0.5%
- Metilpropanodiol Methylpropanediol
- 0,5% 0.5%
- Fenoxietanol Phenoxyethanol
- 0,3% 0.3%
- Parabeno Paraben
- 0,3% 0.3%
- Creatina Creatine
- 0,2% 0.2%
- Tocoferilacetato Tocopheryl acetate
- 0,5% 0.5%
- Glicerina Glycerin
- 5% 5%
- Pigmento de óxido férrico Ferric oxide pigment
- 1% one%
- Perfume Fragrance
- c.s. c.s.
- agua Water
- hasta 100 up to 100
Claims (15)
- 1. Preparado cosmético y/o dermatológico a base de una emulsión Ag/Ac en forma de bolas o esferoides estables y/o rígidos, semirígidos a una temperatura de 35ºC con un volumen de 0,1 hasta 20 ml que contienen básicamente lípidos, emulgentes, polímeros naturales y/o sintéticos y/o mezclas de los mismos, que se caracteriza porque el preparado consta de una mezcla estable en forma de lípido/emulgente, el agua dispersada con un tamaño de gotas inferior a 50 micrómetros. 5 1. Cosmetic and / or dermatological preparation based on an Ag / Ac emulsion in the form of stable and / or rigid balls or spheroids, semi-rigid at a temperature of 35 ° C with a volume of 0.1 to 20 ml containing basically lipids, emulsifiers , natural and / or synthetic polymers and / or mixtures thereof, characterized in that the preparation consists of a stable mixture in the form of a lipid / emulsifier, the dispersed water with a droplet size of less than 50 micrometers. 5
- 2. Preparado conforme a la reivindicación 1, que se caracteriza porque las ceras se eligen del grupo del palmitato de cetilo, ricinoleato de cetilo, cera de abeja, cocoglicérido hidratado, palmitato de metilo, cera de Candelilla, cera de Carnauba, cera de parafina, ceresina, ozokerita, miristato de miristilo, tripalmitina, tribehenina, palmitoestearato de glicerilo, aceite de colza hidratado, y estearato de alquilestearilo C15-40. 2. Prepared according to claim 1, characterized in that the waxes are chosen from the group of cetyl palmitate, cetyl ricinoleate, beeswax, hydrated cocoglyceride, methyl palmitate, Candelilla wax, Carnauba wax, paraffin wax , ceresin, ozokerite, myristyl myristate, tripalmitin, tribehenin, glyceryl palmitosterate, hydrated rapeseed oil, and C15-40 alkylstearyl stearate.
- 3. Preparado conforme a una de las reivindicaciones 1 ó 2, que se caracteriza porque el preparado 10 contiene ceras que se eligen de las ceras microcristalinas, ceras de parafina, ceras de ésteres, ceras de glicéridos, así como alcoholes grasos y emulgentes sólidos y sus mezclas. 3. Prepared according to one of claims 1 or 2, characterized in that the preparation 10 contains waxes that are chosen from microcrystalline waxes, paraffin waxes, ester waxes, glyceride waxes, as well as fatty alcohols and solid emulsifiers and their mixtures
- 4. Preparado conforme a una de las reivindicaciones anteriores, que se caracteriza porque presenta un diámetro medio de 3 hasta 40 mm. 4. Prepared according to one of the preceding claims, characterized in that it has an average diameter of 3 to 40 mm.
- 5. Preparado conforme a una de las reivindicaciones anteriores, que se caracteriza porque contiene 15 además sustancias auxiliares, filtros de rayos UV, pigmentos, sustancias activas, colorantes, aditivos sensoriales, espesantes, formadores de gel, medios conservantes, antioxidantes, formadores de complejos, sustancias gustativas, desnaturalizantes, principios activos y/o perfume. 5. Prepared according to one of the preceding claims, characterized in that it also contains auxiliary substances, UV filters, pigments, active substances, colorants, sensory additives, thickeners, gel-forming agents, preservative media, antioxidants, complexing agents. , taste substances, denaturants, active ingredients and / or perfume.
- 6. Preparado conforme a una de las reivindicaciones anteriores, que se caracteriza porque cada uno de los preparados en forma de bolas se recubre de una envuelta con cubierta de envasado exterior. 20 6. Prepared according to one of the preceding claims, characterized in that each of the preparations in the form of balls is coated in an envelope with an outer packaging cover. twenty
- 7. Preparado conforme a una de las reivindicaciones anteriores, que se caracteriza porque los preparados en forma de bolas se envasan individualmente o bien varios en envase de papel, metal o plástico. 7. Prepared according to one of the preceding claims, characterized in that the ball-shaped preparations are individually packaged or several in paper, metal or plastic packaging.
- 8. Preparado conforme a una de las reivindicaciones anteriores, que se caracteriza porque los preparados en forma de bolas se envasan individualmente o bien varios en envase en forma de blister de papel, metal o plástico. 25 8. Prepared according to one of the preceding claims, characterized in that the preparations in the form of balls are individually packaged or several packaged in the form of paper, metal or plastic blister packs. 25
- 9. Preparado conforme a una de las reivindicaciones anteriores con un envase de blister para la extracción individual de cada uno de los preparados en forma de bolas. 9. Prepared according to one of the preceding claims with a blister pack for the individual extraction of each of the preparations in the form of balls.
- 10. Utilización del preparado conforme a una de las reivindicaciones anteriores para la aplicación tópica sobre la piel y/o el cabello. 10. Use of the preparation according to one of the preceding claims for topical application on the skin and / or hair.
- 11. Uso del preparado conforme a la reivindicación 10 para aplicar los cosméticos sin dejar residuos. 30 11. Use of the preparation according to claim 10 to apply the cosmetics without leaving residues. 30
- 12. Uso del preparado conforme a la reivindicación 10 o 11 para la aplicación individual. 12. Use of the preparation according to claim 10 or 11 for individual application.
- 13. Método para la aplicación de preparados cosméticos y/o dermatológicos conforme a una de las reivindicaciones 1 hasta 9 para la aplicación tópica, de forma que los preparados al frotar y extenderse por la piel y/o el cabello 13. Method for the application of cosmetic and / or dermatological preparations according to one of claims 1 to 9 for topical application, so that the preparations when rubbing and spreading through the skin and / or hair
- - se funden y/o 35 - merge and / or 35
- - debido a las fuerzas de cizalladura se licúan total o parcialmente y/o - due to the shear forces they are totally or partially liquefied and / or
- - se disuelven total o parcialmente en los lípidos del sebo cutáneo. - they dissolve completely or partially in the skin sebum lipids.
- 14. Método para la aplicación de preparados cosméticos y/o dermatológicos conforme a la reivindicación 13 de manera que se extraen uno o varios preparados en forma de bola de un envase y se aplican frotando la piel y/o el cabello. 40 14. Method for applying cosmetic and / or dermatological preparations according to claim 13 so that one or more ball-shaped preparations are removed from a container and applied by rubbing the skin and / or hair. 40
- 15. Combinación que consta de varios preparados en forma de bola conforme a una de las reivindicaciones 1 hasta 9, que se caracteriza porque al menos dos de los preparados en forma de bola se diferencian en su aspecto, presentan contenidos diferentes y/o sirven para fines distintos. 15. A combination consisting of several ball-shaped preparations according to one of claims 1 to 9, characterized in that at least two of the ball-shaped preparations differ in appearance, have different contents and / or serve to different purposes
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10339747 | 2003-08-27 | ||
DE10339747 | 2003-08-27 | ||
DE10340106 | 2003-08-30 | ||
DE10357640 | 2003-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2354883T3 true ES2354883T3 (en) | 2011-03-18 |
Family
ID=43640336
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES04764494T Expired - Lifetime ES2354883T3 (en) | 2003-08-27 | 2004-08-26 | COSMETIC PREPARATIONS IN BALL FORM FOR THE TOPICAL APPLICATION. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2354883T3 (en) |
-
2004
- 2004-08-26 ES ES04764494T patent/ES2354883T3/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8741321B2 (en) | Capsule whose envelope is separately imperceptible during the topical use thereof | |
US8435546B2 (en) | Cosmetic, dermatological or pharmaceutical preparations of lipid/wax mixtures containing gases | |
US6503518B1 (en) | Reduced lipid flowable preparations | |
US20140227330A1 (en) | Capsule whose envelope is separately imperceptible during the topical use thereof | |
ES2208900T3 (en) | COSMETIC OR PHARMACEUTICAL PREPARATIONS WITH LOWER SENSATION OF STICK. | |
ES2282502T3 (en) | COSMETIC AND DERMATOLOGICAL PREPARATIONS TO RELIEF THE PRURITE. | |
ES2279186T3 (en) | SPRAYABLE WATER / OIL EMULSIONS LIKE AN AEROSOL. | |
TWI679024B (en) | Foaming skincare formulations | |
ES2607903T5 (en) | Perfumed cosmetic preparation | |
ES2426601T3 (en) | Cosmetic formula with glycosyl glycerides and powdered raw materials | |
JP2005508919A (en) | Cosmetic and dermatological sticks | |
US8741320B2 (en) | Spherical cosmetic preparations for topical application | |
US20160367959A1 (en) | Multiphase Compositions | |
ES2264935T3 (en) | WATER TYPE SYSTEMS IN OIL FREE OF EMULSIFIER AND FINALLY DISPERSED. | |
ES2259239T3 (en) | FLUID PREPARATIONS OF WATER / OIL EMULSION TYPE WITH A HIGH WATER CONTENT. | |
ES2291529T3 (en) | STABILIZATION OF ACTIVE PRINCIPLES SENSITIVE TO OXIDATION AND / OR UV RAYS. | |
ES2240612T3 (en) | FOAMABLE PREPARATIONS. | |
ES2354883T3 (en) | COSMETIC PREPARATIONS IN BALL FORM FOR THE TOPICAL APPLICATION. | |
JP6783511B2 (en) | Topical skin agent |